1
|
Béchu C, Rullier A, Lesoin PE, Gaillot-Durand L, Trecourt A, Gosset P, Tilmant C. The carbon footprint of a surgical pathology laboratory in France. Am J Clin Pathol 2024:aqae022. [PMID: 38470223 DOI: 10.1093/ajcp/aqae022] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2023] [Accepted: 01/29/2024] [Indexed: 03/13/2024] Open
Abstract
OBJECTIVES The health sector contributes to climate disruption through greenhouse gas (GHG) emissions. It accounts for 8% to 10% of France's GHG emissions. Although the medical community has been alerted to the problem, more data are needed. This study aimed to determine the carbon footprint of a surgical pathology laboratory. METHODS The study was conducted in the surgical pathology laboratory at Saint Vincent hospital (Lille) in 2021. It represented 17,242 patient cases corresponding to 54,124 paraffin blocks. The 17 staff members performed cytology, immunohistochemistry, and in situ hybridization. The study included all inputs, capital equipment, freight, travel, energy consumption, and waste. Carbon emission factors were based on the French Agence De l'Environnement et de la Maîtrise de l'Energie database. RESULTS In 2021, the pathology laboratory's carbon footprint was 117 tons of CO2 equivalent (t CO2e), corresponding to 0.5% of Saint Vincent hospital's total emissions. The most significant emissions categories were inputs (60 t CO2e; 51%), freight associated with inputs (24 t CO2e; 20%), and travel (14 t CO2e; 12%). Waste and energy generated 10 t CO2e (9%) and 9 t CO2e (8%), respectively. CONCLUSIONS The pathology laboratory's carbon footprint was equivalent to the yearly carbon impact of 11 French inhabitants. This footprint is dominated by inputs and associated freight. This suggests an urgent need to develop ecodesign and self-sufficiency in our routine practices.
Collapse
Affiliation(s)
| | | | | | | | | | - Pierre Gosset
- Service d'ACP, Hôpital Saint Vincent de Paul, GHICL, Lille, France
| | - Cyprien Tilmant
- Service d'ACP, Hôpital Saint Vincent de Paul, GHICL, Lille, France
| |
Collapse
|
2
|
Annesi-Maesano I, Bonniaud P, Bouchaud G, Boyer L, Gazzeri S, Gosset P, Gras D, Guibert C, Guignabert C, Mari B, Matecki S, Morélot C, Pilette C, Planes C, Plantier L, Polette M, Si-Tahar M, Taillé C, Vachier I. [Triumphant return of the J2R 2023 at Tours: A whirlwind of scientific exchanges and emotion]. Rev Mal Respir 2024; 41:180-182. [PMID: 38514243 DOI: 10.1016/j.rmr.2024.03.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/23/2024]
Affiliation(s)
- I Annesi-Maesano
- Institut Desbrest d'épidémiologie et santé publique (IDESP), Inserm, université de Montpellier, Montpellier, France
| | - P Bonniaud
- Service de pneumologie et soins intensifs respiratoires, Inserm UMR 1231, Centre de référence constitutif des maladies pulmonaires rares de l'adulte, centre hospitalo-universitaire de Dijon-Bourgogne, UFR des sciences de santé, université de Bourgogne-Franche Comté, Dijon, France
| | | | - L Boyer
- Service de physiologie, hôpital Henri-Mondor, AP-HP, université Paris Est Créteil, Inserm, IMRB, Créteil, France
| | - S Gazzeri
- Institut pour l'avancée des biosciences (IAB), Inserm U1209, CNRS UMR 5309, université Grenoble Alpes, La Tronche, France
| | - P Gosset
- CNRS UMR9017, Inserm U1019, Institut Pasteur de Lille, Center for Infection and Immunity of Lille (CIIL), CHRU de Lille, université de Lille, Lille, France
| | - D Gras
- Aix-Marseille université, Inserm, INRAE, C2VN, Marseille, France
| | - C Guibert
- Inserm, Centre de recherche cardiothoracique de Bordeaux, U1045, Pessac, université de Bordeaux, Bordeaux, France
| | - C Guignabert
- Inserm, hypertension pulmonaire : physiopathologie et innovation thérapeutique, université Paris-Saclay, 92350 Le Plessis-Robinson, France
| | - B Mari
- CNRS, Institut de pharmacologie moléculaire et cellulaire (IPMC), université Côte d'Azur, Sophia-Antipolis, France
| | - S Matecki
- PHYMEDEXP, UMR CNRS 9214, Inserm U1046, université de Montpellier, CHU de Montpellier, Montpellier, France
| | - C Morélot
- Service de pneumologie, département R3S, GHU, AP-HP-Sorbonne université, site Pitié-Salpêtrière, UMR-S 1158 Inserm, neurophysiologie respiratoire expérimentale et clinique, Paris cedex 13, France
| | - C Pilette
- Service de pneumologie, cliniques universitaires Saint-Luc, pôle pneumologie, ORL et dermatologie, Institut de recherche expérimentale et clinique, UCLouvain, Louvain, Belgique
| | - C Planes
- Service de physiologie-explorations fonctionnelles, hôpital Avicenne, HUPSSD, AP-HP, « Hypoxie & Poumon » Inserm U1272, UFR SMBH Bobigny, université Sorbonne Paris Nord, Paris, France
| | - L Plantier
- Service de pneumologie et exploration fonctionnelle respiratoire, CEPR/Inserm UMR1100, CHRU de Tours, université de Tours, Tours, France
| | - M Polette
- Inserm UMR-S 1250, université de Reims Champagne-Ardenne, Reims, France
| | - M Si-Tahar
- Inserm, Centre d'étude des pathologies respiratoires (CEPR), UMR 1100, université de Tours, Tours, France
| | - C Taillé
- Service de pneumologie et centre de référence constitutif des maladies pulmonaires rares, Inserm UMR1152, AP-HP Nord, université de Paris, Paris, France
| | - I Vachier
- Département de pneumologie, médecine biologie méditerranée, CHU de Montpellier, Montpellier, France.
| |
Collapse
|
3
|
Barbier E, Carpentier J, Simonin O, Gosset P, Platel A, Happillon M, Alleman LY, Perdrix E, Riffault V, Chassat T, Lo Guidice JM, Anthérieu S, Garçon G. Oxidative stress and inflammation induced by air pollution-derived PM 2.5 persist in the lungs of mice after cessation of their sub-chronic exposure. Environ Int 2023; 181:108248. [PMID: 37857188 DOI: 10.1016/j.envint.2023.108248] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 08/12/2023] [Revised: 09/28/2023] [Accepted: 10/03/2023] [Indexed: 10/21/2023]
Abstract
More than 7 million early deaths/year are attributable to air pollution. Current health concerns are especially focused on air pollution-derived particulate matter (PM). Although oxidative stress-induced airway inflammation is one of the main adverse outcome pathways triggered by air pollution-derived PM, the persistence of both these underlying mechanisms, even after exposure cessation, remained poorly studied. In this study, A/JOlaHsd mice were also exposed acutely (24 h) or sub-chronically (4 weeks), with or without a recovery period (12 weeks), to two urban PM2.5 samples collected during contrasting seasons (i.e., autumn/winter, AW or spring/summer, SS). The distinct intrinsic oxidative potentials (OPs) of AW and SS PM2.5, as evaluated in acellular conditions, were closely related to their respective physicochemical characteristics and their respective ability to really generate ROS over-production in the mouse lungs. Despite the early activation of the nuclear factor erythroid 2-related factor 2 (Nrf2) cell signaling pathway by AW and, in a lesser degree, SS PM2.5, in the murine lungs after acute and sub-chronic exposures, the critical redox homeostasis was not restored, even after the exposure cessation. Accordingly, an inflammatory response was reported through the activation of the nuclear factor-kappa B (NF-κB) cell signaling pathway activation, the secretion of cytokines, and the recruitment of inflammatory cells, in the murine lungs after the acute and sub-chronic exposures to AW and, in a lesser extent, to SS PM2.5, which persisted after the recovery period. Taken together, these original results provided, for the first time, new relevant insights that air pollution-derived PM2.5, with relatively high intrinsic OPs, induced oxidative stress and inflammation, which persisted admittedly at a lower level in the lungs after the exposure cessation, thereby contributing to the occurrence of molecular and cellular adverse events leading to the development and/or exacerbation of future chronic inflammatory lung diseases and even cancers.
Collapse
Affiliation(s)
- Emeline Barbier
- Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR4483-IMPECS, France
| | - Jessica Carpentier
- Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR4483-IMPECS, France
| | - Ophélie Simonin
- Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR4483-IMPECS, France
| | - Pierre Gosset
- Service d'Anatomo-pathologie, Hôpital Saint Vincent de Paul, Lille, France
| | - Anne Platel
- Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR4483-IMPECS, France
| | - Mélanie Happillon
- Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR4483-IMPECS, France
| | - Laurent Y Alleman
- IMT Nord Europe, Institut Mines-Télécom, Univ. Lille, Centre for Energy and Environment, Lille, France
| | - Esperanza Perdrix
- IMT Nord Europe, Institut Mines-Télécom, Univ. Lille, Centre for Energy and Environment, Lille, France
| | - Véronique Riffault
- IMT Nord Europe, Institut Mines-Télécom, Univ. Lille, Centre for Energy and Environment, Lille, France
| | - Thierry Chassat
- Institut Pasteur de Lille, Plateforme d'Expérimentation et de Haute Technologie Animale, Lille, France
| | | | | | - Guillaume Garçon
- Univ. Lille, CHU Lille, Institut Pasteur de Lille, ULR4483-IMPECS, France.
| |
Collapse
|
4
|
Folcher A, Gordienko D, Iamshanova O, Bokhobza A, Shapovalov G, Kannancheri‐Puthooru D, Mariot P, Allart L, Desruelles E, Spriet C, Diez R, Oullier T, Marionneau‐Lambot S, Brisson L, Geraci S, Impheng H, Lehen'kyi V, Haustrate A, Mihalache A, Gosset P, Chadet S, Retif S, Laube M, Sobilo J, Lerondel S, Villari G, Serini G, Pla AF, Roger S, Fromont‐Hankard G, Djamgoz M, Clezardin P, Monteil A, Prevarskaya N. NALCN-mediated sodium influx confers metastatic prostate cancer cell invasiveness. EMBO J 2023; 42:e112198. [PMID: 37278161 PMCID: PMC10308360 DOI: 10.15252/embj.2022112198] [Citation(s) in RCA: 4] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2022] [Revised: 05/09/2023] [Accepted: 05/10/2023] [Indexed: 06/07/2023] Open
Abstract
There is growing evidence that ion channels are critically involved in cancer cell invasiveness and metastasis. However, the molecular mechanisms of ion signaling promoting cancer behavior are poorly understood and the complexity of the underlying remodeling during metastasis remains to be explored. Here, using a variety of in vitro and in vivo techniques, we show that metastatic prostate cancer cells acquire a specific Na+ /Ca2+ signature required for persistent invasion. We identify the Na+ leak channel, NALCN, which is overexpressed in metastatic prostate cancer, as a major initiator and regulator of Ca2+ oscillations required for invadopodia formation. Indeed, NALCN-mediated Na+ influx into cancer cells maintains intracellular Ca2+ oscillations via a specific chain of ion transport proteins including plasmalemmal and mitochondrial Na+ /Ca2+ exchangers, SERCA and store-operated channels. This signaling cascade promotes activity of the NACLN-colocalized proto-oncogene Src kinase, actin remodeling and secretion of proteolytic enzymes, thus increasing cancer cell invasive potential and metastatic lesions in vivo. Overall, our findings provide new insights into an ion signaling pathway specific for metastatic cells where NALCN acts as persistent invasion controller.
Collapse
Affiliation(s)
- Antoine Folcher
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| | - Dmitri Gordienko
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| | - Oksana Iamshanova
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| | - Alexandre Bokhobza
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| | - George Shapovalov
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| | - Dheeraj Kannancheri‐Puthooru
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| | - Pascal Mariot
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| | - Laurent Allart
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| | - Emilie Desruelles
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| | - Corentin Spriet
- TISBio, Unité de Glycobiologie Structurale et Fonctionnelle (UGSF), CNRS, UMR 8576Université de LilleLilleFrance
| | - Raquel Diez
- Cell Physiology Research Group, Department of PhysiologyUniversity of ExtremaduraCáceresSpain
| | | | | | - Lucie Brisson
- Inserm UMR1069, Nutrition Croissance et CancerUniversity of ToursToursFrance
| | - Sandra Geraci
- Univ Lyon, Université Claude Bernard Lyon 1, Inserm UMR 1033 LYOSLyonFrance
| | - Hathaichanok Impheng
- Department of Physiology, Faculty of Medical scienceNaresuan UniversityPhitsanulokThailand
| | - V'yacheslav Lehen'kyi
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| | - Aurélien Haustrate
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| | - Adriana Mihalache
- Service d'Anatomie et de Cytologie PathologiquesGroupement des Hôpitaux de l'Université Catholique de LilleLilleFrance
| | - Pierre Gosset
- Service d'Anatomie et de Cytologie PathologiquesGroupement des Hôpitaux de l'Université Catholique de LilleLilleFrance
| | - Stéphanie Chadet
- EA4245 Transplantation, Immunology, InflammationUniversity of ToursToursFrance
| | - Stéphanie Retif
- PHENOMIN‐TAAM, CNRS UPS44, Centre d'Imagerie du Petit Animal (CIPA), 3B rue de la FérollerieOrléansFrance
| | - Maryline Laube
- PHENOMIN‐TAAM, CNRS UPS44, Centre d'Imagerie du Petit Animal (CIPA), 3B rue de la FérollerieOrléansFrance
| | - Julien Sobilo
- PHENOMIN‐TAAM, CNRS UPS44, Centre d'Imagerie du Petit Animal (CIPA), 3B rue de la FérollerieOrléansFrance
| | - Stéphanie Lerondel
- PHENOMIN‐TAAM, CNRS UPS44, Centre d'Imagerie du Petit Animal (CIPA), 3B rue de la FérollerieOrléansFrance
| | - Giulia Villari
- Department of OncologyUniversity of Torino School of MedicineCandioloItaly
- Candiolo Cancer Institute – Fondazione del Piemonte per l'Oncologia (FPO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)CandioloItaly
| | - Guido Serini
- Department of OncologyUniversity of Torino School of MedicineCandioloItaly
- Candiolo Cancer Institute – Fondazione del Piemonte per l'Oncologia (FPO), Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)CandioloItaly
| | | | - Sébastien Roger
- EA4245 Transplantation, Immunology, InflammationUniversity of ToursToursFrance
| | - Gaelle Fromont‐Hankard
- Inserm UMR1069, Nutrition Croissance et CancerUniversity of ToursToursFrance
- Department of PathologyCHRU de ToursToursFrance
| | - Mustafa Djamgoz
- Department of Life SciencesImperial College LondonLondonUK
- Biotechnology Research CentreCyprus International UniversityMersinTürkiye
| | - Philippe Clezardin
- Univ Lyon, Université Claude Bernard Lyon 1, Inserm UMR 1033 LYOSLyonFrance
| | - Arnaud Monteil
- LabEx “Ion Channel Science and Therapeutics”, IGF, CNRS, INSERMUniversity of MontpellierMontpellierFrance
| | - Natalia Prevarskaya
- Inserm U1003, Laboratory of Excellence, Ion Channels Science and Therapeutics, Equipe Labellisée par la Ligue Nationale Contre le Cancer, GIS ONCO LilleUniversity of LilleLilleFrance
| |
Collapse
|
5
|
Sermet K, Grandjean T, Bontemps E, Tardy M, Gosset P, Faure E. EpITRANS, impact of immunosuppressive drugs on epithelial immunity in acute respiratory infections of solid organ transplant recipients. Rev Mal Respir 2023. [DOI: 10.1016/j.rmr.2022.11.053] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/18/2023]
|
6
|
Haustrate A, Mihalache A, Cordier C, Gosset P, Prevarskaya N, Lehen’kyi V. A Novel Anti-TRPV6 Antibody and Its Application in Cancer Diagnosis In Vitro. Int J Mol Sci 2022; 24:ijms24010419. [PMID: 36613866 PMCID: PMC9820453 DOI: 10.3390/ijms24010419] [Citation(s) in RCA: 4] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Revised: 12/13/2022] [Accepted: 12/15/2022] [Indexed: 12/28/2022] Open
Abstract
Though the first discovery of TRPV6 channel expression in various tissues took place in the early 2000s, reliable tools for its protein detection in various cells and tissues are still missing. Here we show the generation and validation of rabbit polyclonal anti-TRPV6 channel antibodies (rb79-82) against four epitopes of 15 amino acids. Among them, only one antibody, rb79, was capable of detecting the full-length glycosylated form of the TRPV6 channel at around 100 kDa. The generated antibody was shown to be suitable for all in vitro applications, such as immunoblotting, immunoprecipitation, immunocytochemistry, immunofluorescence, etc. One of the most important applications is immunohistochemistry using the paraffin-embedded sections from cancer resection specimens. Using prostate cancer resection specimens, we have confirmed the absence of the TRPV6 protein in both healthy and benign hyperplasia, as well as its expression and correlation to the prostate cancer grades. Thus, the generated rabbit polyclonal anti-TRPV6 channel antibody rb79 is suitable for all in vitro diagnostic applications and particularly for the diagnosis in clinics using paraffin-embedded sections from patients suffering from various diseases and disorders involving the TRPV6 channel.
Collapse
Affiliation(s)
- Aurélien Haustrate
- Laboratory of Cell Physiology, INSERM U1003, Laboratory of Excellence Ion Channels Science and Therapeutics, Department of Biology, Faculty of Science and Technologies, University of Lille, 59650 Villeneuve d’Ascq, France
- FONDATION ARC, 9 rue Guy Môquet, 94830 Villejuif, France
| | - Adriana Mihalache
- Service d’Anatomie et de Cytologie Pathologiques, Groupement des Hôpitaux de l’Institut Catholique de Lille (GHICL), 59000 Lille, France
| | - Clément Cordier
- Laboratory of Cell Physiology, INSERM U1003, Laboratory of Excellence Ion Channels Science and Therapeutics, Department of Biology, Faculty of Science and Technologies, University of Lille, 59650 Villeneuve d’Ascq, France
| | - Pierre Gosset
- Service d’Anatomie et de Cytologie Pathologiques, Groupement des Hôpitaux de l’Institut Catholique de Lille (GHICL), 59000 Lille, France
| | - Natalia Prevarskaya
- Laboratory of Cell Physiology, INSERM U1003, Laboratory of Excellence Ion Channels Science and Therapeutics, Department of Biology, Faculty of Science and Technologies, University of Lille, 59650 Villeneuve d’Ascq, France
| | - V’yacheslav Lehen’kyi
- Laboratory of Cell Physiology, INSERM U1003, Laboratory of Excellence Ion Channels Science and Therapeutics, Department of Biology, Faculty of Science and Technologies, University of Lille, 59650 Villeneuve d’Ascq, France
- FONDATION ARC, 9 rue Guy Môquet, 94830 Villejuif, France
- Correspondence: ; Tel.: +33-3-2033-7078
| |
Collapse
|
7
|
Cochard M, Ledoux F, Cazier F, Gosset P, Courcot D, Landkocz Y. P13-04 Toxicity of airborne particulate matter in port, industrial and urban areas and effects on epithelial-to-mesenchymal transition in lung A549 cells. Toxicol Lett 2022. [DOI: 10.1016/j.toxlet.2022.07.543] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
8
|
Barbier E, Carpentier J, Gosset P, Simonin O, Anthérieu S, Alleman L, Perdrix E, Guidice JML, Garçon G. SOC-III-04 Oxidative stress and inflammation induced by air pollution-derived ultrafine particles chronic exposure in mice: a multiorgan approach. Toxicol Lett 2022. [DOI: 10.1016/j.toxlet.2022.07.138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
9
|
Annesi-Maesano I, Bonniaud P, Bouchaud G, Boyer L, Gazzeri S, Gosset P, Gras D, Guibert C, Guignabert C, Mari B, Matecki S, Morélot C, Pilette C, Planes C, Plantier L, Polette M, Si-Tahar M, Taillé C, Vachier I. RESPIRenT : RESeau de Pneumologie en Innovation et Recherche translaTionnelle, un nouveau souffle pour les J2R. Rev Mal Respir 2022; 39:73-74. [DOI: 10.1016/j.rmr.2022.01.011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/05/2022] [Accepted: 01/05/2022] [Indexed: 11/27/2022]
|
10
|
Kalach N, Misak Z, Bontems P, Kori M, Homan M, Cabral J, Casswall T, Chong S, Cilleruelo ML, Faraci S, Megraud F, Papadopoulou A, Pehlivanoglu E, Raymond J, Rea F, Maria R, Roma E, Tavares M, Ugras M, Urbonas V, Urruzuno P, Gosset P, Creusy C, Delebarre M, Verdun S. Systematic Review and Meta-analysis of Histological Gastric Biopsy Aspects According to the Updated Sydney System in Children. J Pediatr Gastroenterol Nutr 2022; 74:13-19. [PMID: 34338237 DOI: 10.1097/mpg.0000000000003259] [Citation(s) in RCA: 2] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Abstract
OBJECTIVES A descriptive and comparative study of gastric histological aspects according to the updated Sydney classification (USC), obtained from Helicobacter pylori-positive versus H pylori-negative children referred for upper gastrointestinal endoscopy. METHODS The Prisma method was used to perform a systematic review and meta-analysis. Selection criteria were based on following key words USC, H pylori, children, endoscopy, or biopsy. Publication biases were assessed according to the Newcastle-Ottawa Scale, and a meta-regression analysis was done. The study was registered on the PROSPERO platform. RESULTS Between 1994 and 2017, 1238 references were found; 97 studies were retained for the systematic review with a total number of 25,867 children; 75 studies were selected for the meta-analysis concerning 5990 H pylori-infected and 17,782 uninfected children.H pylori-positive versus H pylori-negative children, according to the USC, showed significantly higher relative risk for gastric antral and corpus chronic inflammation, presence of neutrophils, and of lymphoid follicles, and gastric mucosa atrophy, whereas, intestinal metaplasia showed a significantly higher RR only in antral biopsies. The meta-regression analysis showed that H pylori-positive versus H pylori-negative children had significantly higher risk only for corpus activity according to age, recurrent abdominal pain, and geographical area of low H pylori prevalence. CONCLUSIONS H pylori infection in children was associated with higher relative risk for gastric antral and corpus chronic inflammation, presence of neutrophils, lymphoid follicles, and rare gastric mucosa atrophy, whereas, rare intestinal metaplasia was only significantly higher in the antral area.
Collapse
Affiliation(s)
- Nicolas Kalach
- Pediatric Clinic, Saint Vincent de Paul Hospital, Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL), Catholic University of Lille, Lille, France
| | - Zrinjka Misak
- Department of Pediatrics, Referral Center for Pediatric Gastroenterology and Nutrition, Children's Hospital Zagreb, Zagreb, Croatia
| | - Patrick Bontems
- Department of Gastroenterology, Hôpital Universitaire des Enfants Reine Fabiola, Université Libre de Bruxelles, Belgium
| | - Michal Kori
- Kaplan Medical Center, Pediatric Gastroenterology Unit, Rehovot, Israel
| | - Matjaz Homan
- Department of Gastroenterology, Hepatology and Nutrition, Faculty of Medicine, University Children's Hospital Ljubljana, Ljubljana, Slovenia
| | - José Cabral
- Hospital of Dona Estefania, CHLC, Pediatric Gastroenterology Unit, Lisbon, Portugal
| | - Thomas Casswall
- Karolinska University Hospital, Department of Pediatrics, Stockholm, Sweden
| | - Sonny Chong
- Queen Mary's Hospital for children Epsom & St Helier NHS Trust Carshalton, Surrey, United Kingdom
| | - Maria Luz Cilleruelo
- Hospital Universitario Puerta de Hierro-Majadahonda, Pediatric Gastroenterology Unit, Madrid, Spain
| | - Simona Faraci
- Bambino Gesù Children's Hospital, Digestive Endoscopy and Surgery Unit, Rome, Italy
| | - Francis Megraud
- INSERM U1053, University of Bordeaux, & National Reference Centre for Campylobacter and Helicobacter, Hospital Pellegrin, Bordeaux, France
| | - Alexandra Papadopoulou
- Division of Gastroenterology & Hepatology, First Department of Pediatrics, University of Athens, Agia Sofia Children's Hospital, Athens, Greece
| | - Ender Pehlivanoglu
- Department of Child Health & Nutrition, Istanbul Kent University, Istanbul, Turkey
| | - Josette Raymond
- Microbiology Department, Cochin Hospital, Assistances Publiques des Hôpitaux de Paris (AP-HP), University René Descartes Paris V, Paris, France
| | - Francesca Rea
- Bambino Gesù Children's Hospital, Digestive Endoscopy and Surgery Unit, Rome, Italy
| | - Rogalidou Maria
- Division of Gastroenterology & Hepatology, First Department of Pediatrics, University of Athens, Agia Sofia Children's Hospital, Athens, Greece
| | | | - Marta Tavares
- Unidade de Gastrenterologia Pediátrica do Centro Materno Infantil do Norte, Centro Hospitalar Universitário do Porto, Porto, Portugal
| | - Meltem Ugras
- Yeditepe University Medical Faculty, Department of Pediatrics, Gastroenterology, Hepatology and Nutrition, Ataşehir, Istanbul, Turkey
| | - Vaidotas Urbonas
- Vilnius University Clinic of Children's Diseases, Vilnius, Lithuania
| | - Pedro Urruzuno
- Hospital Universitario Doce de Octubre, Servicio de Pediatria, Madrid, Spain
| | - Pierre Gosset
- Pathology Department, Saint Vincent de Paul Hospital, Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL), Catholic University of Lille
| | - Colette Creusy
- Pathology Department, Saint Vincent de Paul Hospital, Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL), Catholic University of Lille
| | - Mathilde Delebarre
- Pediatric Clinic, Saint Vincent de Paul Hospital, Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL), Catholic University of Lille, Lille, France
| | - Stephane Verdun
- Department of Medical Research, Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL), Lille Catholic Hospital, Lille, France
| |
Collapse
|
11
|
Le Guern R, Stabler S, Gosset P, Pichavant M, Grandjean T, Faure E, Karaca Y, Faure K, Kipnis E, Dessein R. Colonization resistance against multi-drug-resistant bacteria: a narrative review. J Hosp Infect 2021; 118:48-58. [PMID: 34492304 DOI: 10.1016/j.jhin.2021.09.001] [Citation(s) in RCA: 15] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/30/2021] [Revised: 09/01/2021] [Accepted: 09/01/2021] [Indexed: 12/15/2022]
Abstract
Colonization resistance by gut microbiota is a fundamental phenomenon in infection prevention and control. Hospitalized patients may be exposed to multi-drug-resistant bacteria when hand hygiene compliance among healthcare workers is not adequate. An additional layer of defence is provided by the healthy gut microbiota, which helps clear the exogenous bacteria and acts as a safety net when hand hygiene procedures are not followed. This narrative review focuses on the role of the gut microbiota in colonization resistance against multi-drug-resistant bacteria, and its implications for infection control. The review discusses the underlying mechanisms of colonization resistance (direct or indirect), the concept of resilience of the gut microbiota, the link between the antimicrobial spectrum and gut dysbiosis, and possible therapeutic strategies. Antimicrobial stewardship is crucial to maximize the effects of colonization resistance. Avoiding unnecessary antimicrobial therapy, shortening the antimicrobial duration as much as possible, and favouring antibiotics with low anti-anaerobe activity may decrease the acquisition and expansion of multi-drug-resistant bacteria. Even after antimicrobial therapy, the resilience of the gut microbiota often occurs spontaneously. Spontaneous resilience explains the existence of a window of opportunity for colonization of multi-drug-resistant bacteria during or just after antimicrobial therapy. Strategies favouring resilience of the gut microbiota, such as high-fibre diets or precision probiotics, should be evaluated.
Collapse
Affiliation(s)
- R Le Guern
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Centre for Infection and Immunity of Lille, Lille, France; Laboratoire de Bactériologie-Hygiène, CHU Lille, Lille, France.
| | - S Stabler
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Centre for Infection and Immunity of Lille, Lille, France; Service de Maladies Infectieuses, CHU Lille, Lille, France
| | - P Gosset
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Centre for Infection and Immunity of Lille, Lille, France
| | - M Pichavant
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Centre for Infection and Immunity of Lille, Lille, France
| | - T Grandjean
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Centre for Infection and Immunity of Lille, Lille, France
| | - E Faure
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Centre for Infection and Immunity of Lille, Lille, France; Service de Maladies Infectieuses, CHU Lille, Lille, France
| | - Y Karaca
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Centre for Infection and Immunity of Lille, Lille, France
| | - K Faure
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Centre for Infection and Immunity of Lille, Lille, France; Service de Maladies Infectieuses, CHU Lille, Lille, France
| | - E Kipnis
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Centre for Infection and Immunity of Lille, Lille, France; Service de Réanimation Chirurgicale, CHU Lille, Lille, France
| | - R Dessein
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, Centre for Infection and Immunity of Lille, Lille, France; Laboratoire de Bactériologie-Hygiène, CHU Lille, Lille, France
| |
Collapse
|
12
|
Dusautoir R, Zarcone G, Platel A, Kervoaze G, Laine W, Kluza J, Nesslany F, Gosset P, Garçon G, Anthérieu S, Lo Guidice JM. Long-term respiratory impact of electronic cigarette. Toxicol Lett 2021. [DOI: 10.1016/s0378-4274(21)00429-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
13
|
Lagrafeuille R, Fangous M, Guilloux C, Gouriou S, Gosset P, Vallet S, Héry-Arnaud G, Le Berre R. Intranasal or oral Lactobacilli administration: Which one is best for fighting against Pseudomonas aeruginosa (PA) respiratory tract infections? Rev Mal Respir 2021. [DOI: 10.1016/j.rmr.2021.02.032] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
14
|
Annesi-Maesano I, Bonniaud P, Bouchaud G, Boyer L, Frossard N, Gazzeri S, Gosset P, Gras D, Guibert C, Guignabert C, Mari B, Matecki S, Morelot C, Pilette C, Planes C, Plantier L, Polette M, Si-Tahar M, Taillé C, Vachier I. [Tonnerre de Brest! 2020 Respiratory Research Days like no others…]. Rev Mal Respir 2021; 38:565-566. [PMID: 34024643 DOI: 10.1016/j.rmr.2021.05.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/30/2021] [Accepted: 03/30/2021] [Indexed: 11/16/2022]
Affiliation(s)
- I Annesi-Maesano
- Institut Desbrest d'Épidémiologie et Santé Publique (IDESP), Inserm - Université de Montpellier, Montpellier, France
| | - P Bonniaud
- Centre de Référence Constitutif des Maladies Pulmonaires Rares de l'Adulte, Service de Pneumologie et Soins Intensifs Respiratoires, Centre Hospitalo-Universitaire de Dijon-Bourgogne - UFR des Sciences de Santé, Université de Bourgogne-Franche Comté - Inserm UMR 1231, Dijon, France
| | | | - L Boyer
- Service de Physiologie, Hôpital Henri Mondor, AP-HP, Univ Paris Est Creteil, Inserm, IMRB, Creteil, France
| | - N Frossard
- Laboratoire d'Innovation Thérapeutique, UMR 7200 CNRS - Université de Strasbourg, Illkirch, France
| | - S Gazzeri
- RNA Splicing, Cell Signaling and Response to Therapies Team Centre de recherche UGA, Inserm U1209, CNRS UMR 5309, La Tronche, France
| | - P Gosset
- University Lille, CNRS UMR9017, Inserm U1019, CHRU Lille, Institut Pasteur de Lille, CIIL - Center for Infection and Immunity of Lille, Lille, France
| | - D Gras
- Aix-Marseille Univ, Inserm, INRAE, C2VN, Marseille, France
| | - C Guibert
- Inserm, Centre de Recherche Cardio-Thoracique de Bordeaux, U1045, Pessac - Université de Bordeaux, Bordeaux, France
| | - C Guignabert
- Inserm UMR_S 999 « Pulmonary Hypertension : Pathophysiology and Novel Therapies », Hôpital Marie Lannelongue, Le Plessis-Robinson - Université Paris-Saclay, Faculté de Médecine, Le Kremlin-Bicêtre, France
| | - B Mari
- Université Côte d'Azur, CNRS, Institut de Pharmacologie Moléculaire et Cellulaire (IPMC), Sophia Antipolis, France
| | - S Matecki
- PHYMEDEXP, UMR CNRS 9214, Inserm U1046-Université de Montpellier Montpellier - CHU Montpellier, Montpellier, France
| | - C Morelot
- Service de Pneumologie, Département R3S, GHU, APHP-Sorbonne Université, site Pitié Salpêtrière - UMR-S 1158 Inserm - Sorbonne Université, Neurophysiologie Respiratoire Expérimentale et Clinique, Paris Cedex 13, France
| | - C Pilette
- Service de pneumologie, Cliniques universitaires Saint-Luc - Pôle pneumologie, ORL et dermatologie, Institut de Recherche Expérimentale et Clinique, UCLouvain, Louvain, Belgique
| | - C Planes
- Service de Physiologie-Explorations Fonctionnelles, Hôpital Avicenne, HUPSSD, AP-HP - "Hypoxie & Poumon" Inserm U1272, UFR SMBH Bobigny, Université Sorbonne Paris Nord, Paris, France
| | - L Plantier
- Service de Pneumologie et Exploration Fonctionnelle Respiratoire, CHRU de Tours - CEPR/Inserm UMR1100, Université de Tours, Tours, France
| | - M Polette
- Inserm UMR-S 1250, Université de Reims Champagne-Ardenne, Reims, France
| | - M Si-Tahar
- Inserm, Centre d'Étude des Pathologies Respiratoires (CEPR), UMR 1100 - Université de Tours, Tours, France
| | - C Taillé
- Service de pneumologie et centre de référence constitutif des maladies pulmonaires rares, AP-HP Nord - Université de Paris, Paris, France
| | - I Vachier
- Coordinatrice du groupe J2R (-) Département de Pneumologie, CHU Montpellier, Médecine Biologie Méditerranée, Montpellier, France.
| | | |
Collapse
|
15
|
Pérez-Cruz M, Koné B, Porte R, Carnoy C, Tabareau J, Gosset P, Trottein F, Sirard JC, Pichavant M, Gosset P. The Toll-Like Receptor 5 agonist flagellin prevents Non-typeable Haemophilus influenzae-induced infection in cigarette smoke-exposed mice. PLoS One 2021; 16:e0236216. [PMID: 33784296 PMCID: PMC8009382 DOI: 10.1371/journal.pone.0236216] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2020] [Accepted: 02/25/2021] [Indexed: 01/13/2023] Open
Abstract
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality worldwide. The major bacterial cause of COPD exacerbations is non-typeable Haemophilus influenzae (NTHi). 25 to over 80% of cases are associated with NTHi. This susceptibility to infection involves a defective production of interleukin (IL)-22 which plays an important role in mucosal defense. Prophylactic administration of flagellin, a Toll-like receptor 5 (TLR5) agonist, protects healthy mice against respiratory pathogenic bacteria. We hypothesized that TLR5-mediated stimulation of lung immunity might prevent COPD exacerbations. Mice chronically exposed to cigarette smoke (CS), which presented COPD symptoms, were infected with NTHi and intraperitoneally treated with recombinant flagellin following a prophylactic or therapeutic protocol. Compared with control, cigarette smoke-exposed mice treated with flagellin showed a lower bacterial load in the airways, the lungs and the blood. This protection was associated with an early neutrophilia, a lower production of pro-inflammatory cytokines and an increased IL-22 production. Flagellin treatment decreased the recruitment of inflammatory cells and the lung damages related to exacerbation. Morover, the protective effect of flagellin against NTHi was altered by treatment with anti-IL-22 blocking antibodies in cigarette smoke-exposed mice and in Il22-/- mice. The effect of flagellin treatment did not implicated the anti-bacterial peptides calgranulins and defensin-β2. This study shows that stimulation of innate immunity by a TLR5 ligand is a potent antibacterial treatment in CS-exposed mice, suggesting innovative therapeutic strategies against acute exacerbation in COPD.
Collapse
Affiliation(s)
- Magdiel Pérez-Cruz
- Univ. Lille, CNRS UMR9017, Inserm U1019, CHRU Lille, Institut Pasteur de Lille, CIIL—Center for Infection and Immunity of Lille, Lille, France
| | - Bachirou Koné
- Univ. Lille, CNRS UMR9017, Inserm U1019, CHRU Lille, Institut Pasteur de Lille, CIIL—Center for Infection and Immunity of Lille, Lille, France
| | - Rémi Porte
- Univ. Lille, CNRS UMR9017, Inserm U1019, CHRU Lille, Institut Pasteur de Lille, CIIL—Center for Infection and Immunity of Lille, Lille, France
| | - Christophe Carnoy
- Univ. Lille, CNRS UMR9017, Inserm U1019, CHRU Lille, Institut Pasteur de Lille, CIIL—Center for Infection and Immunity of Lille, Lille, France
| | - Julien Tabareau
- Univ. Lille, CNRS UMR9017, Inserm U1019, CHRU Lille, Institut Pasteur de Lille, CIIL—Center for Infection and Immunity of Lille, Lille, France
| | - Pierre Gosset
- Service d’Anatomo-pathologie, Hôpital Saint Vincent de Paul, Lille, France
| | - François Trottein
- Univ. Lille, CNRS UMR9017, Inserm U1019, CHRU Lille, Institut Pasteur de Lille, CIIL—Center for Infection and Immunity of Lille, Lille, France
| | - Jean-Claude Sirard
- Univ. Lille, CNRS UMR9017, Inserm U1019, CHRU Lille, Institut Pasteur de Lille, CIIL—Center for Infection and Immunity of Lille, Lille, France
| | - Muriel Pichavant
- Univ. Lille, CNRS UMR9017, Inserm U1019, CHRU Lille, Institut Pasteur de Lille, CIIL—Center for Infection and Immunity of Lille, Lille, France
| | - Philippe Gosset
- Univ. Lille, CNRS UMR9017, Inserm U1019, CHRU Lille, Institut Pasteur de Lille, CIIL—Center for Infection and Immunity of Lille, Lille, France
| |
Collapse
|
16
|
Bar S, Levivier C, Dupont H, Gosset P. Validation of the COVILUS score to diagnose COVID-19 in an emergency room cohort. Anaesthesia 2021; 76:1134-1135. [PMID: 33621362 PMCID: PMC8013858 DOI: 10.1111/anae.15450] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 01/30/2021] [Indexed: 11/27/2022]
Affiliation(s)
- S Bar
- Amiens University Hospital, Amiens, France
| | - C Levivier
- Amiens University Hospital, Amiens, France
| | - H Dupont
- Amiens University Hospital, Amiens, France
| | - P Gosset
- Amiens University Hospital, Amiens, France
| |
Collapse
|
17
|
Lecureur V, Monteil C, Jaguin M, Cazier F, Preterre D, Corbière C, Gosset P, Douki T, Sichel F, Fardel O. Comparative study on gene expression profile in rat lung after repeated exposure to diesel and biodiesel exhausts upstream and downstream of a particle filter. Environ Pollut 2020; 266:115264. [PMID: 32771839 DOI: 10.1016/j.envpol.2020.115264] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/17/2020] [Revised: 06/19/2020] [Accepted: 07/13/2020] [Indexed: 06/11/2023]
Abstract
Biodiesel is considered as a valuable and less toxic alternative to diesel. However, cellular and molecular effects of repeated exposure to biodiesel emissions from a recent engine equipped with a diesel particle filter (DPF) remain to be characterized. To gain insights about this point, the lung transcriptional signatures were analyzed for rats (n = 6 per group) exposed to filtered air, 30% rapeseed biodiesel (B30) blend or reference diesel (RF0), upstream and downstream a DPF, for 3 weeks (3 h/day, 5 days/week). Genomic analysis revealed a modest regulation of gene expression level (lower than a 2-fold) by both fuels and a higher number of genes regulated downstream the DPF than upstream, in response to either RF0 or to B30 exhaust emissions. The presence of DPF was found to notably impact the lung gene signature of rats exposed to B30. The number of genes regulated in common by both fuels was low, which is likely due to differences in concentrations of regulated pollutants in exhausts, notably for compound organic volatiles, polycyclic aromatic hydrocarbons, NO or NOx. Nevertheless, we have identified some pathways that were activated for both exhaust emissions, such as integrin-, IGF-1- and Rac-signaling pathways, likely reflecting the effects of gas phase products. By contrast, some canonical pathways relative to "oxidative phosphorylation" and "mitochondrial dysfunction" appear as specific to B30 exhaust emission; the repression of transcripts of mitochondrial respiratory chain in lung of rats exposed to B30 downstream of DPF supports the perturbation of mitochondria function. This study done with a recent diesel engine (compliant with the European IV emission standard) and commercially-available fuels reveals that the diesel blend composition and the presence of an after treatment system may modify lung gene signature of rats repeatedly exposed to exhaust emissions, however in a rather modest manner.
Collapse
Affiliation(s)
- Valérie Lecureur
- Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, 35000, Rennes, France.
| | - Christelle Monteil
- Normandie Univ, UNIROUEN, UNICAEN, ABTE, 14000, Caen et 76000 Rouen, France
| | - Marie Jaguin
- Univ Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, 35000, Rennes, France
| | - Fabrice Cazier
- Common Center of Measurements (CCM), Univ. Littoral Côte d'Opale, 59140, Dunkerque, France
| | - David Preterre
- CERTAM, 1 rue Joseph Fourier, 76800, Saint-Etienne du Rouvray, France
| | - Cécile Corbière
- Normandie Univ, UNIROUEN, UNICAEN, ABTE, 14000, Caen et 76000 Rouen, France
| | - Pierre Gosset
- Unité de Chimie Environnementale et Interactions sur le Vivant, EA4492, Université du Littoral Côte d'Opale, Dunkerque, France
| | - Thierry Douki
- Univ. Grenoble Alpes, CEA, CNRS, INAC, SyMMES/CIBEST, F-38000, Grenoble, France
| | - François Sichel
- Normandie Univ, UNIROUEN, UNICAEN, ABTE, 14000, Caen et 76000 Rouen, France; Centre François Baclesse, 14000, Caen, France
| | - Olivier Fardel
- Univ Rennes, CHU Rennes, Inserm, EHESP, Irset (Institut de Recherche en Santé, Environnement et Travail), UMR_S 1085, 35000, Rennes, France
| |
Collapse
|
18
|
Koné B, Pérez‐Cruz M, Porte R, Hennegrave F, Carnoy C, Gosset P, Trottein F, Sirard J, Pichavant M, Gosset P. Boosting the IL-22 response using flagellin prevents bacterial infection in cigarette smoke-exposed mice. Clin Exp Immunol 2020; 201:171-186. [PMID: 32324274 PMCID: PMC7366752 DOI: 10.1111/cei.13445] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/24/2019] [Revised: 03/27/2020] [Accepted: 04/10/2020] [Indexed: 12/29/2022] Open
Abstract
The progression of chronic obstructive pulmonary disease (COPD), a lung inflammatory disease being the fourth cause of death worldwide, is marked by acute exacerbations. These episodes are mainly caused by bacterial infections, frequently due to Streptococcus pneumoniae. This susceptibility to infection involves a defect in interleukin (IL)-22, which plays a pivotal role in mucosal defense mechanism. Administration of flagellin, a Toll-like receptor 5 (TLR-5) agonist, can protect mice and primates against respiratory infections in a non-pathological background. We hypothesized that TLR-5-mediated stimulation of innate immunity might improve the development of bacteria-induced exacerbations in a COPD context. Mice chronically exposed to cigarette smoke (CS), mimicking COPD symptoms, are infected with S. pneumoniae, and treated in a preventive and a delayed manner with flagellin. Both treatments induced a lower bacterial load in the lungs and blood, and strongly reduced the inflammation and lung lesions associated with the infection. This protection implicated an enhanced production of IL-22 and involved the recirculation of soluble factors secreted by spleen cells. This is also associated with higher levels of the S100A8 anti-microbial peptide in the lung. Furthermore, human mononuclear cells from non-smokers were able to respond to recombinant flagellin by increasing IL-22 production while active smoker cells do not, a defect associated with an altered IL-23 production. This study shows that stimulation of innate immunity by a TLR-5 ligand reduces CS-induced susceptibility to bacterial infection in mice, and should be considered in therapeutic strategies against COPD exacerbations.
Collapse
Affiliation(s)
- B. Koné
- Université de LilleCNRSInsermCHU LilleInstitut Pasteur de LilleLilleFrance
| | - M. Pérez‐Cruz
- Université de LilleCNRSInsermCHU LilleInstitut Pasteur de LilleLilleFrance
| | - R. Porte
- Université de LilleCNRSInsermCHU LilleInstitut Pasteur de LilleLilleFrance
| | - F. Hennegrave
- Université de LilleCNRSInsermCHU LilleInstitut Pasteur de LilleLilleFrance
| | - C. Carnoy
- Université de LilleCNRSInsermCHU LilleInstitut Pasteur de LilleLilleFrance
| | - P. Gosset
- Service d’Anatomo‐pathologieHôpital Saint Vincent de PaulLilleFrance
| | - F. Trottein
- Université de LilleCNRSInsermCHU LilleInstitut Pasteur de LilleLilleFrance
| | - J.‐C. Sirard
- Université de LilleCNRSInsermCHU LilleInstitut Pasteur de LilleLilleFrance
| | - M. Pichavant
- Université de LilleCNRSInsermCHU LilleInstitut Pasteur de LilleLilleFrance
| | - P. Gosset
- Université de LilleCNRSInsermCHU LilleInstitut Pasteur de LilleLilleFrance
| |
Collapse
|
19
|
Bar S, Lecourtois A, Diouf M, Goldberg E, Bourbon C, Arnaud E, Domisse L, Dupont H, Gosset P. The association of lung ultrasound images with COVID-19 infection in an emergency room cohort. Anaesthesia 2020; 75:1620-1625. [PMID: 32520406 PMCID: PMC7300460 DOI: 10.1111/anae.15175] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 06/09/2020] [Indexed: 12/16/2022]
Abstract
Lung ultrasound could facilitate the triage of patients with suspected COVID‐19 infection admitted to the emergency room. We developed a predictive model for COVID‐19 diagnosis based on lung ultrasound and clinical features. We used ultrasound to image the lung bilaterally at two anterior sites, one and two hands below each clavicle, and a posterolateral site that was the posterior transverse continuation from the lower anterior site. We studied 100 patients, 31 of whom had a COVID‐19 positive reverse transcriptase polymerase chain reaction. A positive test was independently associated with: quick sequential organ failure assessment score ≥1; ≥3 B‐lines at the upper site; consolidation and thickened pleura at the lower site; and thickened pleura line at the posterolateral site. The model discrimination was an area (95%CI) under the receiver operating characteristic curve of 0.82 (0.75–0.90). The characteristics (95%CI) of the model’s diagnostic threshold, applied to the population from which it was derived, were: sensitivity, 97% (83–100%); specificity, 62% (50–74%); positive predictive value, 54% (41–98%); and negative predictive value, 98% (88–99%). This model may facilitate triage of patients with suspected COVID‐19 infection admitted to the emergency room.
Collapse
Affiliation(s)
- S Bar
- Anaesthesiology and Critical Care Department, Amiens University Hospital, Amiens, France
| | - A Lecourtois
- Emergency Medicine Department, Amiens University Hospital, Amiens, France
| | - M Diouf
- Amiens University Hospital, Amiens, France
| | - E Goldberg
- Anaesthesiology and Critical Care Department, Amiens University Hospital, Amiens, France
| | - C Bourbon
- Emergency Medicine Department, Amiens University Hospital, Amiens, France
| | - E Arnaud
- Emergency Medicine Department, Amiens University Hospital, Amiens, France
| | - L Domisse
- Emergency Medicine Department, Amiens University Hospital, Amiens, France
| | - H Dupont
- Anaesthesiology and Critical Care Department, Amiens University Hospital, Amiens, France
| | - P Gosset
- Emergency Medicine Department, Amiens University Hospital, Amiens, France
| |
Collapse
|
20
|
Al Zallouha M, Landkocz Y, Méausoone C, Ledoux F, Visade F, Cazier F, Martin PJ, Borgie M, Vitagliano JJ, Trémolet G, Cailliez JC, Gosset P, Courcot D, Billet S. A prospective pilot study of the T-lymphocyte response to fine particulate matter exposure. J Appl Toxicol 2020; 40:619-630. [PMID: 31975422 DOI: 10.1002/jat.3932] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Exposure to air pollution is associated with increased morbidity and mortality. Once the fine atmospheric particulate matter (FP) is inhaled, some of its compounds can pass through the lungs and reach the bloodstream where they can come into contact with immune cells. Exposure to FP particularly affects sensitive populations such as the elderly. Aging affects the immune system, making the elderly more vulnerable. The project aims to determine the effects of FP exposure on human T cells while looking for biomarkers associated with exposure. Blood samples from 95 healthy subjects in three different age groups (20-30, 45-55 and 70-85 years) were collected to determine a potential age effect. T lymphocytes were isolated to be exposed ex vivo for 72 hours to 45 μg/mL of FP collected in Dunkirk and chemically characterized. Overexpression of the CYP1A1, CYP1B1 and CYP2S1 genes was therefore measured after exposure of the T cells to FP. These genes code for enzymes known to be involved in the metabolic activation of organic compounds such as polycyclic aromatic hydrocarbons detected in the FP sample. T-cell profiling allowed us to suggest a mixed T-helper 1/2 profile caused by exposure to FP. With regard to the influence of age, we have observed differences in the expression of certain genes, as well as an increase in interleukin-4 and -13 concentrations in the elderly. These results showed that exposure of T lymphocytes to FP causes effects on both transcriptomic and cytokine secretion levels.
Collapse
Affiliation(s)
- Margueritta Al Zallouha
- EA 4492 - UCEIV - Unité de Chimie Environnementale et Interactions sur le Vivant, Université du Littoral Côte d'Opale, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Yann Landkocz
- EA 4492 - UCEIV - Unité de Chimie Environnementale et Interactions sur le Vivant, Université du Littoral Côte d'Opale, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Clémence Méausoone
- EA 4492 - UCEIV - Unité de Chimie Environnementale et Interactions sur le Vivant, Université du Littoral Côte d'Opale, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Fréderic Ledoux
- EA 4492 - UCEIV - Unité de Chimie Environnementale et Interactions sur le Vivant, Université du Littoral Côte d'Opale, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Fabien Visade
- Service de gériatrie, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France
| | - Fabrice Cazier
- Centre Commun de Mesures, Université Littoral Côte d'Opale, Dunkerque, France
| | - Perrine J Martin
- EA 4492 - UCEIV - Unité de Chimie Environnementale et Interactions sur le Vivant, Université du Littoral Côte d'Opale, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Mireille Borgie
- EA 4492 - UCEIV - Unité de Chimie Environnementale et Interactions sur le Vivant, Université du Littoral Côte d'Opale, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Jean-Jacques Vitagliano
- Direction de la Recherche Médicale, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France
| | - Gauthier Trémolet
- EA 4492 - UCEIV - Unité de Chimie Environnementale et Interactions sur le Vivant, Université du Littoral Côte d'Opale, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | | | - Pierre Gosset
- Service d'Anatomie pathologique, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France
| | - Dominique Courcot
- EA 4492 - UCEIV - Unité de Chimie Environnementale et Interactions sur le Vivant, Université du Littoral Côte d'Opale, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Sylvain Billet
- EA 4492 - UCEIV - Unité de Chimie Environnementale et Interactions sur le Vivant, Université du Littoral Côte d'Opale, SFR Condorcet FR CNRS 3417, Dunkerque, France
| |
Collapse
|
21
|
Billet S, Landkocz Y, Martin PJ, Verdin A, Ledoux F, Lepers C, André V, Cazier F, Sichel F, Shirali P, Gosset P, Courcot D. Chemical characterization of fine and ultrafine PM, direct and indirect genotoxicity of PM and their organic extracts on pulmonary cells. J Environ Sci (China) 2018; 71:168-178. [PMID: 30195675 DOI: 10.1016/j.jes.2018.04.022] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2017] [Revised: 04/19/2018] [Accepted: 04/20/2018] [Indexed: 06/08/2023]
Abstract
Particulate matter in ambient air constitutes a complex mixture of fine and ultrafine particles composed of various chemical compounds including metals, ions, and organics. A multidisciplinary approach was developed by studying physico-chemical characteristics and mechanisms involved in the toxicity of particulate atmospheric pollution. PM0.3-2.5 and PM2.5 including ultrafine particles were sampled in Dunkerque, a French industrialized seaside city. PM samples were characterized from a chemical and toxicological point of view. Physico-chemical characterization evidenced that PM2.5 comes from several sources: natural ones, such as soil resuspension and marine sea-salt emissions, as well as anthropogenic ones, such as shipping traffic, road traffic, and industrial activities. Human BEAS-2B lung cells were exposed to PM0.3-2.5, or to the Extractable Organic Matter (EOM) of PM0.3-2.5 and PM2.5. These exposures induced several mechanisms of action implied in the genotoxicity, such as oxidative DNA adducts and DNA Damage Response. The toxicity of PM-EOM was higher for the sample including the ultrafine fraction (PM2.5) containing also higher concentrations of polycyclic aromatic hydrocarbons. These results evidenced the major role of organic compounds in the toxicity of PM.
Collapse
Affiliation(s)
- Sylvain Billet
- University of the Littoral Opal Coast, Unit of Environmental Chmistry and Interactions with Living Organisms, UCEIV EA4492, SFR Condorcet FR CNRS 3417, Dunkerque, France.
| | - Yann Landkocz
- University of the Littoral Opal Coast, Unit of Environmental Chmistry and Interactions with Living Organisms, UCEIV EA4492, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Perrine J Martin
- University of the Littoral Opal Coast, Unit of Environmental Chmistry and Interactions with Living Organisms, UCEIV EA4492, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Anthony Verdin
- University of the Littoral Opal Coast, Unit of Environmental Chmistry and Interactions with Living Organisms, UCEIV EA4492, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Frédéric Ledoux
- University of the Littoral Opal Coast, Unit of Environmental Chmistry and Interactions with Living Organisms, UCEIV EA4492, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Capucine Lepers
- University of the Littoral Opal Coast, Unit of Environmental Chmistry and Interactions with Living Organisms, UCEIV EA4492, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | | | - Fabrice Cazier
- University of the Littoral Opal Coast, Common Centre of Measurements, CCM, Dunkerque, France
| | - François Sichel
- Normandy Univ, UNICAEN, ABTE EA4651, Caen, France; Centre François Baclesse, Caen, France
| | - Pirouz Shirali
- University of the Littoral Opal Coast, Unit of Environmental Chmistry and Interactions with Living Organisms, UCEIV EA4492, SFR Condorcet FR CNRS 3417, Dunkerque, France
| | - Pierre Gosset
- University of the Littoral Opal Coast, Unit of Environmental Chmistry and Interactions with Living Organisms, UCEIV EA4492, SFR Condorcet FR CNRS 3417, Dunkerque, France; Department of Anatomy and Pathological Cytology, Saint-Vincent Hospital, Catholic Hospital, Lille, France
| | - Dominique Courcot
- University of the Littoral Opal Coast, Unit of Environmental Chmistry and Interactions with Living Organisms, UCEIV EA4492, SFR Condorcet FR CNRS 3417, Dunkerque, France
| |
Collapse
|
22
|
Lezmi G, Deschildre A, Abou Taam R, Fayon M, Blanchon S, Troussier F, Mallinger P, Mahut B, Gosset P, de Blic J. Remodelling and inflammation in preschoolers with severe recurrent wheeze and asthma outcome at school age. Clin Exp Allergy 2018; 48:806-813. [PMID: 29603800 DOI: 10.1111/cea.13143] [Citation(s) in RCA: 19] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/23/2017] [Revised: 02/24/2018] [Accepted: 03/03/2018] [Indexed: 12/30/2022]
Abstract
BACKGROUND The influence of airway remodelling and inflammation in preschoolers with severe recurrent wheeze on asthma outcomes is poorly understood. OBJECTIVE To assess their association with asthma symptoms and lung function at school age. METHODS Preschoolers (38.4 months) initially investigated with bronchial biopsies were re-assessed for asthma symptoms and lung function at school age. RESULTS Thirty-six of 49 preschoolers (73.5%) were assessed at 10.9 years. Twenty-six (72.2%) had persistent asthma. Submucosal eosinophil counts were higher in children with severe exacerbations at school age than in those without (16/0.1 mm2 [11.2-30.4] vs 8/0.1 mm2 [2.4-17.6], P = .02), and correlated with the number of severe exacerbations (P = .04, r = .35). Submucosal neutrophil counts correlated with FEV1/FVC (P < .01, r = .47) and FEF25-75% predicted (P = .02, r = .43). Airway smooth muscle (ASM) area correlated with FEV1/FVC (P < .01, r = .51). Vessel numbers negatively correlated with FEV1% predicted and FEV1/FVC (P = .03, r = -.42; P = .04, r = -.41; respectively) and FEF25-75% predicted (P = .02, r = -.46). CONCLUSION Eosinophilic inflammation in preschoolers with severe recurrent wheeze might be predictive of future severe exacerbations, neutrophilia might be associated with better lung function. Changes in ASM and vascularity might affect lung function at school age.
Collapse
Affiliation(s)
- G Lezmi
- Service de Pneumologie et Allergologie Pédiatriques, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,Université Paris Descartes, Paris, France
| | - A Deschildre
- Unité de Pneumologie-Allergologie Pédiatrique, Clinique de Pédiatrie Jeanne de Flandre, CHRU de Lille, Université Nord de France, Lille, France
| | - R Abou Taam
- Service de Pneumologie et Allergologie Pédiatriques, Hôpital Universitaire Necker-Enfants Malades, Paris, France
| | - M Fayon
- Centre de Recherche Cardio-thoracique de Bordeaux, Université de Bordeaux, Bordeaux, France.,CHU de Bordeaux, Centre d'Investigation Clinique (CIC 1401), Bordeaux, France
| | - S Blanchon
- Unité de Pneumologie et Allergologie Pédiatrique, Centre de Compétences des Maladies Respiratoires Rares, Hôpitaux Universitaire de Toulouse, Toulouse, France
| | - F Troussier
- Centre de Ressources et de Compétences en Mucoviscidose Enfants, Service de Pédiatrie, Centre Hospitalier Universitaire, Angers, France
| | - P Mallinger
- Cabinet de Pneumologie et d'Allergologie des Sardières, Bourg-en-Bresse, France
| | - B Mahut
- Cabinet La Berma, Antony, France
| | - P Gosset
- Centre d'Infection et d'Immunité de Lille, Institut Pasteur de Lille, Lille, France.,Centre National de la Recherche Scientifique, Lille, France.,Institut National de la Santé et de la Recherche Médicale, Lille, France.,Institut Fédératif de la Recherche 142, Lille, France
| | - J de Blic
- Service de Pneumologie et Allergologie Pédiatriques, Hôpital Universitaire Necker-Enfants Malades, Paris, France.,Université Paris Descartes, Paris, France
| |
Collapse
|
23
|
Douki T, Corbière C, Preterre D, Martin PJ, Lecureur V, André V, Landkocz Y, Pottier I, Keravec V, Fardel O, Moreira-Rebelo S, Pottier D, Vendeville C, Dionnet F, Gosset P, Billet S, Monteil C, Sichel F. Comparative study of diesel and biodiesel exhausts on lung oxidative stress and genotoxicity in rats. Environ Pollut 2018; 235:514-524. [PMID: 29324381 DOI: 10.1016/j.envpol.2017.12.077] [Citation(s) in RCA: 18] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 07/17/2017] [Revised: 12/13/2017] [Accepted: 12/21/2017] [Indexed: 06/07/2023]
Abstract
The contribution of diesel exhaust to atmospheric pollution is a major concern for public health, especially in terms of occurrence of lung cancers. The present study aimed at addressing the toxic effects of a repeated exposure to these emissions in an animal study performed under strictly controlled conditions. Rats were repeatedly exposed to the exhaust of diesel engine. Parameters such as the presence of a particle filter or the use of gasoil containing rapeseed methyl ester were investigated. Various biological parameters were monitored in the lungs to assess the toxic and genotoxic effects of the exposure. First, a transcriptomic analysis showed that some pathways related to DNA repair and cell cycle were affected to a limited extent by diesel but even less by biodiesel. In agreement with occurrence of a limited genotoxic stress in the lungs of diesel-exposed animals, small induction of γ-H2AX and acrolein adducts was observed but not of bulky adducts and 8-oxodGuo. Unexpected results were obtained in the study of the effect of the particle filter. Indeed, exhausts collected downstream of the particle filter led to a slightly higher induction of a series of genes than those collected upstream. This result was in agreement with the formation of acrolein adducts and γH2AX. On the contrary, induction of oxidative stress remained very limited since only SOD was found to be induced and only when rats were exposed to biodiesel exhaust collected upstream of the particle filter. Parameters related to telomeres were identical in all groups. In summary, our results point to a limited accumulation of damage in lungs following repeated exposure to diesel exhausts when modern engines and relevant fuels are used. Yet, a few significant effects are still observed, mostly after the particle filter, suggesting a remaining toxicity associated with the gaseous or nano-particular phases.
Collapse
Affiliation(s)
- Thierry Douki
- Univ. Grenoble Alpes, CEA, CNRS, INAC, SyMMES/CIBEST, F-38000 Grenoble, France
| | - Cécile Corbière
- Normandie Univ, UNICAEN, UNIROUEN, ABTE, 14000 Caen et 76000, Rouen, France
| | - David Preterre
- Normandie Univ, UNICAEN, UNIROUEN, ABTE, 14000 Caen et 76000, Rouen, France; CERTAM, 1 Rue Joseph Fourier, 76800 Saint-Etienne du Rouvray, France
| | - Perrine J Martin
- Unité de Chimie Environnementale et Interactions sur le Vivant, EA4492, Université du Littoral Côte d'Opale, Dunkerque, France
| | - Valérie Lecureur
- Institut de Recherches en Santé, Environnement et Travail (IRSET), UMR INSERM U1085, Faculté de Pharmacie, 35043 Rennes, France
| | - Véronique André
- Normandie Univ, UNICAEN, UNIROUEN, ABTE, 14000 Caen et 76000, Rouen, France
| | - Yann Landkocz
- Unité de Chimie Environnementale et Interactions sur le Vivant, EA4492, Université du Littoral Côte d'Opale, Dunkerque, France
| | - Ivannah Pottier
- Normandie Univ, UNICAEN, UNIROUEN, ABTE, 14000 Caen et 76000, Rouen, France
| | - Veronika Keravec
- Normandie Univ, UNICAEN, UNIROUEN, ABTE, 14000 Caen et 76000, Rouen, France; CERTAM, 1 Rue Joseph Fourier, 76800 Saint-Etienne du Rouvray, France
| | - Olivier Fardel
- Institut de Recherches en Santé, Environnement et Travail (IRSET), UMR INSERM U1085, Faculté de Pharmacie, 35043 Rennes, France; Pôle Biologie, Centre Hospitalier Universitaire, Rennes, France
| | | | - Didier Pottier
- Normandie Univ, UNICAEN, UNIROUEN, ABTE, 14000 Caen et 76000, Rouen, France
| | - Cathy Vendeville
- Normandie Univ, UNICAEN, UNIROUEN, ABTE, 14000 Caen et 76000, Rouen, France
| | - Frédéric Dionnet
- Normandie Univ, UNICAEN, UNIROUEN, ABTE, 14000 Caen et 76000, Rouen, France; CERTAM, 1 Rue Joseph Fourier, 76800 Saint-Etienne du Rouvray, France
| | - Pierre Gosset
- Unité de Chimie Environnementale et Interactions sur le Vivant, EA4492, Université du Littoral Côte d'Opale, Dunkerque, France
| | - Sylvain Billet
- Unité de Chimie Environnementale et Interactions sur le Vivant, EA4492, Université du Littoral Côte d'Opale, Dunkerque, France
| | - Christelle Monteil
- Normandie Univ, UNICAEN, UNIROUEN, ABTE, 14000 Caen et 76000, Rouen, France
| | - François Sichel
- Normandie Univ, UNICAEN, UNIROUEN, ABTE, 14000 Caen et 76000, Rouen, France; Centre François Baclesse, Caen, France.
| |
Collapse
|
24
|
Dauchy C, Bautin N, Nseir S, Reboux G, Wintjens R, Le Rouzic O, Sendid B, Viscogliosi E, Le Pape P, Arendrup MC, Gosset P, Fry S, Fréalle E. Emergence of Aspergillus fumigatus azole resistance in azole-naïve patients with chronic obstructive pulmonary disease and their homes. Indoor Air 2018; 28:298-306. [PMID: 29082624 DOI: 10.1111/ina.12436] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/09/2017] [Accepted: 10/19/2017] [Indexed: 06/07/2023]
Abstract
Azole-resistant Aspergillus fumigatus (ARAF) has been reported in patients with chronic obstructive pulmonary disease (COPD) but has not been specifically assessed so far. Here, we evaluated ARAF prevalence in azole-naïve COPD patients and their homes, and assessed whether CYP51A mutations were similar in clinical and environmental reservoirs. Sixty respiratory samples from 41 COPD patients with acute exacerbation and environmental samples from 36 of these patient's homes were prospectively collected. A. fumigatus was detected in respiratory samples from 11 of 41 patients (27%) and in 15 of 36 domiciles (42%). Cyp51A sequencing and selection on itraconazole medium of clinical (n = 68) and environmental (n = 48) isolates yielded ARAF detection in 1 of 11 A. fumigatus colonized patients with COPD (9%) and 2 of 15 A. fumigatus-positive patient's homes (13%). The clinical isolate had no CYP51A mutation. Two environmental isolates from two patients harbored TR34 /L98H mutation, and one had an H285Y mutation. Coexistence of different cyp51A genotypes and/or azole resistance profiles was detected in 3 of 8 respiratory and 2 of 10 environmental samples with more than one isolate, confirming the need for a systematic screening of all clinically relevant isolates. The high prevalence of ARAF in patients with COPD and their homes supports the need for further studies to assess the prevalence of azole resistance in patients with Aspergillus diseases in Northern France.
Collapse
Affiliation(s)
- C Dauchy
- CHU Lille, Laboratoire de Parasitologie-Mycologie, Lille, France
| | - N Bautin
- CHU Lille, Department of Respiratory Diseases, Lille, France
| | - S Nseir
- CHU Lille, Critical Care Center, Lille, France
| | - G Reboux
- Chrono-Environnement UMR 6249 CNRS, Université de Bourgogne Franche-Comté & Laboratoire de Parasitologie-Mycologie, CHU de Besançon, Hôpital Jean-Minjoz, Besançon, France
| | - R Wintjens
- Research in Drug Development, Faculté de Pharmacie, Université Libre de Bruxelles, Bruxelles, Belgium
| | - O Le Rouzic
- CHU Lille, Department of Respiratory Diseases, Lille, France
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, Lille, France
| | - B Sendid
- CHU Lille, Laboratoire de Parasitologie-Mycologie, Lille, France
- Inserm U995, Université de Lille, Lille, France
| | - E Viscogliosi
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, Lille, France
| | - P Le Pape
- EA1155-IICiMed, Institut de Recherche en Santé 2, Université de Nantes, Nantes, France
| | - M C Arendrup
- Unit of Mycology, Statens Serum Institut, Copenhagen, Denmark
- Department of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark
- Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark
| | - P Gosset
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, Lille, France
| | - S Fry
- CHU Lille, Department of Respiratory Diseases, Lille, France
| | - E Fréalle
- CHU Lille, Laboratoire de Parasitologie-Mycologie, Lille, France
- University Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Center for Infection and Immunity of Lille, Lille, France
| |
Collapse
|
25
|
Osman M, Benamrouz S, Guyot K, Baydoun M, Frealle E, Chabe M, Gantois N, Delaire B, Goffard A, Aoun A, Jurdi N, Dabboussi F, Even G, Slomianny C, Gosset P, Hamze M, Creusy C, Viscogliosi E, Certad G. High association of Cryptosporidium spp. infection with colon adenocarcinoma in Lebanese patients. PLoS One 2017; 12:e0189422. [PMID: 29261714 PMCID: PMC5736188 DOI: 10.1371/journal.pone.0189422] [Citation(s) in RCA: 32] [Impact Index Per Article: 4.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2017] [Accepted: 11/24/2017] [Indexed: 11/29/2022] Open
Abstract
Background The association between Cryptosporidium and human colon cancer has been reported in different populations. However, this association has not been well studied. In order to add new strong arguments for a probable link between cryptosporidiosis and colon human cancer, the aim of this study was to determine prevalence and to identify species of Cryptosporidium among Lebanese patients. Methodology and principal findings Overall, 218 digestive biopsies were collected in Tripoli, Lebanon, from three groups of patients: (i) patients with recently diagnosed colon intraepithelial neoplasia/adenocarcinoma before any treatment (n = 72); (ii) patients with recently diagnosed stomach intraepithelial neoplasia/adenocarcinoma before any treatment (n = 21); and (iii) patients without digestive intraepithelial neoplasia/adenocarcinoma but with persistent digestive symptoms (n = 125). DNA extraction was performed from paraffin-embedded tissue. The presence of the parasite in tissues was confirmed by PCR, microscopic observation and immunofluorescence analysis. We identified a high rate (21%) of Cryptosporidium presence in biopsies from Lebanese patients with recently diagnosed colonic neoplasia/adenocarcinoma before any treatment. This prevalence was significantly higher compared to 7% of Cryptosporidium prevalence among patients without colon neoplasia but with persistent gastrointestinal symptoms (OR: 4, CI: 1.65–9.6, P = 0.001). When the comparison was done against normal biopsies, the risk of infection increased 11-fold in the group of patients with colon adenocarcinoma (OR: 11.315, CI: 1.44–89.02, P = 0.003). Conclusions This is the first study performed in Lebanon reporting the prevalence of Cryptosporidium among patients with digestive cancer. These results show that Cryptosporidium is strongly associated with human colon cancer being maybe a potential etiological agent of this disease.
Collapse
Affiliation(s)
- Marwan Osman
- Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille (CIIL), UMR CNRS 8204, INSERM U1019, Université de Lille, CHU de Lille, Biologie et Diversité des Pathogènes Eucaryotes Emergents (BDPEE), Lille, France
- Laboratoire Microbiologie Santé et Environnement (LMSE), Ecole Doctorale des Sciences et de Technologie, Faculté de Santé Publique, Université Libanaise, Tripoli, Lebanon
| | - Sadia Benamrouz
- Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille (CIIL), UMR CNRS 8204, INSERM U1019, Université de Lille, CHU de Lille, Biologie et Diversité des Pathogènes Eucaryotes Emergents (BDPEE), Lille, France
- Ecologie et Biodiversité, Faculté de Gestion, Economie et Sciences (FGES), Université Catholique de Lille, Lille, France
| | - Karine Guyot
- Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille (CIIL), UMR CNRS 8204, INSERM U1019, Université de Lille, CHU de Lille, Biologie et Diversité des Pathogènes Eucaryotes Emergents (BDPEE), Lille, France
| | - Martha Baydoun
- Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille (CIIL), UMR CNRS 8204, INSERM U1019, Université de Lille, CHU de Lille, Biologie et Diversité des Pathogènes Eucaryotes Emergents (BDPEE), Lille, France
- BioMEMS, Université de Lille, CNRS, ISEN, UMR 8520 - IEMN, Lille, France
- BioGAP, groupe HEI-ISA-ISEN, Lille, France
| | - Emilie Frealle
- Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille (CIIL), UMR CNRS 8204, INSERM U1019, Université de Lille, CHU de Lille, Biologie et Diversité des Pathogènes Eucaryotes Emergents (BDPEE), Lille, France
- Centre Hospitalier Régional et Universitaire de Lille & Faculté de Médecine de Lille, Université Lille Nord de France, Laboratoire de Parasitologie-Mycologie, Centre de Biologie et Pathologie, Lille, France
| | - Magali Chabe
- Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille (CIIL), UMR CNRS 8204, INSERM U1019, Université de Lille, CHU de Lille, Biologie et Diversité des Pathogènes Eucaryotes Emergents (BDPEE), Lille, France
- Faculté des sciences pharmaceutiques et biologiques, Université Lille Nord de France, Département de Parasitologie–Mycologie, Lille, France
| | - Nausicaa Gantois
- Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille (CIIL), UMR CNRS 8204, INSERM U1019, Université de Lille, CHU de Lille, Biologie et Diversité des Pathogènes Eucaryotes Emergents (BDPEE), Lille, France
| | - Baptiste Delaire
- Service d’Anatomie et de Cytologie Pathologiques, Groupement des Hôpitaux de l’Université Catholique de Lille, Lille, France
| | - Anne Goffard
- Molecular and Cellular Virology, University Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR 8204-CIIL-Centre d’Infection et d’Immunité de Lille, Lille, France
| | - Albert Aoun
- Pathology Department, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
| | - Nawaf Jurdi
- Pathology Department, Faculty of Medicine, American University of Beirut, Beirut, Lebanon
| | - Fouad Dabboussi
- Laboratoire Microbiologie Santé et Environnement (LMSE), Ecole Doctorale des Sciences et de Technologie, Faculté de Santé Publique, Université Libanaise, Tripoli, Lebanon
| | - Gael Even
- Genes Difussion, Douai, France-PEGASE-Biosciences, Lille, France
| | - Christian Slomianny
- Laboratory of Cell Physiology, INSERM U 1003, Université de Lille, Villeneuve d’Ascq, France
| | - Pierre Gosset
- Service d’Anatomie et de Cytologie Pathologiques, Groupement des Hôpitaux de l’Université Catholique de Lille, Lille, France
| | - Monzer Hamze
- Laboratoire Microbiologie Santé et Environnement (LMSE), Ecole Doctorale des Sciences et de Technologie, Faculté de Santé Publique, Université Libanaise, Tripoli, Lebanon
| | - Colette Creusy
- Service d’Anatomie et de Cytologie Pathologiques, Groupement des Hôpitaux de l’Université Catholique de Lille, Lille, France
| | - Eric Viscogliosi
- Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille (CIIL), UMR CNRS 8204, INSERM U1019, Université de Lille, CHU de Lille, Biologie et Diversité des Pathogènes Eucaryotes Emergents (BDPEE), Lille, France
| | - Gabriela Certad
- Institut Pasteur de Lille, Centre d’Infection et d’Immunité de Lille (CIIL), UMR CNRS 8204, INSERM U1019, Université de Lille, CHU de Lille, Biologie et Diversité des Pathogènes Eucaryotes Emergents (BDPEE), Lille, France
- Département de la Recherche Médicale, Groupement des Hôpitaux de l’Institut Catholique de Lille, Faculté de Médecine et Maïeutique, Université Catholique de Lille, Lille, France
- * E-mail:
| |
Collapse
|
26
|
Baydoun M, Vanneste SB, Creusy C, Guyot K, Gantois N, Chabe M, Delaire B, Mouray A, Baydoun A, Forzy G, Chieux V, Gosset P, Senez V, Viscogliosi E, Follet J, Certad G. Three-dimensional (3D) culture of adult murine colon as an in vitro model of cryptosporidiosis: Proof of concept. Sci Rep 2017; 7:17288. [PMID: 29230047 PMCID: PMC5725449 DOI: 10.1038/s41598-017-17304-2] [Citation(s) in RCA: 23] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/20/2017] [Accepted: 11/19/2017] [Indexed: 01/12/2023] Open
Abstract
Cryptosporidium parvum is a major cause of diarrheal illness and was recently potentially associated with digestive carcinogenesis. Despite its impact on human health, Cryptosporidium pathogenesis remains poorly known, mainly due to the lack of a long-term culture method for this parasite. Thus, the aim of the present study was to develop a three-dimensional (3D) culture model from adult murine colon allowing biological investigations of the host-parasite interactions in an in vivo-like environment and, in particular, the development of parasite-induced neoplasia. Colonic explants were cultured and preserved ex vivo for 35 days and co-culturing was performed with C. parvum. Strikingly, the resulting system allowed the reproduction of neoplastic lesions in vitro at 27 days post-infection (PI), providing new evidence of the role of the parasite in the induction of carcinogenesis. This promising model could facilitate the study of host-pathogen interactions and the investigation of the process involved in Cryptosporidium-induced cell transformation.
Collapse
Affiliation(s)
- Martha Baydoun
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France.,ISA-YNCREA Hauts-de-France, Lille, France.,Univ. Lille, CNRS, ISEN, UMR 8520 - IEMN, Lille, France
| | - Sadia Benamrouz Vanneste
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France.,Laboratoire Ecologie et Biodiversité, Faculté de Gestion Economie et Sciences, Institut Catholique de Lille, Lille, France
| | - Colette Creusy
- Service d'Anatomie et de Cytologie Pathologiques, Groupement des Hopitaux de l'Institut Catholique de Lille (GHICL), Lille, France
| | - Karine Guyot
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France
| | - Nausicaa Gantois
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France
| | - Magali Chabe
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France.,Faculté de Pharmacie, Univ. de Lille, Lille, France
| | - Baptiste Delaire
- Service d'Anatomie et de Cytologie Pathologiques, Groupement des Hopitaux de l'Institut Catholique de Lille (GHICL), Lille, France
| | - Anthony Mouray
- Plateforme d'Expérimentations et de Hautes Technologies Animales, Institut Pasteur de Lille, Lille, France
| | - Atallah Baydoun
- Department of Internal Medicine, Case Western Reserve University School of Medicine, Cleveland, OH, USA.,Department of Internal Medicine, Louis Stokes VA Medical Center, Cleveland, OH, USA.,Department of Biomedical Engineering, Case Western Reserve University, Cleveland, OH, USA
| | - Gerard Forzy
- Laboratoire de Biologie Médicale, Groupement des Hospitaux de l'Institut Catholique de Lille (GHICL), Lille, France
| | - Vincent Chieux
- Laboratoire de Biologie Médicale, Groupement des Hospitaux de l'Institut Catholique de Lille (GHICL), Lille, France
| | - Pierre Gosset
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France.,Service d'Anatomie et de Cytologie Pathologiques, Groupement des Hopitaux de l'Institut Catholique de Lille (GHICL), Lille, France
| | - Vincent Senez
- Univ. Lille, CNRS, ISEN, UMR 8520 - IEMN, Lille, France
| | - Eric Viscogliosi
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France
| | - Jérôme Follet
- ISA-YNCREA Hauts-de-France, Lille, France.,Univ. Lille, CNRS, ISEN, UMR 8520 - IEMN, Lille, France
| | - Gabriela Certad
- Univ. Lille, CNRS, Inserm, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France. .,Département de la Recherche Médicale, Groupement des Hopitaux de l'Institut Catholique de Lille (GHICL), Faculté de Médecine et Maïeutique, Université Catholique de Lille, Lille, France.
| |
Collapse
|
27
|
Kalach N, Gosset P, Dehecq E, Decoster A, Georgel AF, Spyckerelle C, Papadopoulos S, Dupont C, Raymond J. A one-step immune-chromatographic Helicobacter pylori stool antigen test for children was quick, consistent, reliable and specific. Acta Paediatr 2017; 106:2025-2030. [PMID: 28667775 DOI: 10.1111/apa.13968] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/04/2017] [Revised: 05/22/2017] [Accepted: 06/27/2017] [Indexed: 12/17/2022]
Abstract
AIM This French study assessed a quick, noninvasive, immuno-chromatographic, Helicobacter pylori (H. pylori) stool antigen test for detecting infections in children. METHODS We enrolled 158 children, with a median age of 8.5 years (range eight months to 17 years), with digestive symptoms suggesting upper gastrointestinal tract disease. Upper digestive endoscopy was performed with gastric biopsy specimens for histology, a rapid urease test, culture test and quantitative real-time polymerase chain reaction. The H. pylori stool antigen test was performed twice for each child and the results were compared to the reference method. RESULTS The reference methods showed that 23 (14.6%) of the 158 children tested were H. pylori positive. The H. pylori stool antigen test showed 91.3% sensitivity, with a 95% confidence interval (95% CI) of 86.9-95.6 and 97% specificity (95% CI 94.3-99.6), 30.84 positive likelihood ratio and 0.09 negative likelihood ratio. The test accuracy was 96.2% (95% CI 93.2-99.1). The two blinded independent observers produced identical H. pylori stool antigen test results and the Kappa coefficient for the H. pylori stool antigen test was one. CONCLUSION The H. pylori stool antigen test was found to be a consistent, reliable, quick and specific test for detecting the H. pylori infection in children.
Collapse
Affiliation(s)
- Nicolas Kalach
- Clinique Pédiatrique St Antoine; Hôpital St Vincent de Paul; Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL); Lille France
- Service de Gastroentérologie Pédiatrique; Hôpital Necker-Enfants-malades; AP-HP; Université Paris Descartes; Paris France
| | - Pierre Gosset
- Département d'Anatomopathologie; Hôpital St Vincent de Paul; GHICL; Lille France
| | - Eric Dehecq
- Département de Microbiologie; Hôpital St Philibert; GHICL; Lille France
| | - Anne Decoster
- Département de Microbiologie; Hôpital St Philibert; GHICL; Lille France
| | | | - Claire Spyckerelle
- Clinique Pédiatrique St Antoine; Hôpital St Vincent de Paul; Groupement des Hôpitaux de l'Institut Catholique de Lille (GHICL); Lille France
| | | | - Christophe Dupont
- Service de Gastroentérologie Pédiatrique; Hôpital Necker-Enfants-malades; AP-HP; Université Paris Descartes; Paris France
| | - Josette Raymond
- Service de Bactériologie; Hôpital Cochin; Université Paris Descartes; Paris France
| |
Collapse
|
28
|
Pierrefiche O, Gosset P, Roger C, Chagas Ricardo J, Robert A, Naassila M, Vilpoux C. S15-4NEUROINFLAMMATION AND EPIGENETIC PROCESSES AFTER ONLY TWO BINGES OF ETHANOL IN YOUNG ADULT RATS. Alcohol Alcohol 2017. [DOI: 10.1093/alcalc/agx075.58] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/14/2022] Open
|
29
|
Vancauwenberghe E, Noyer L, Derouiche S, Lemonnier L, Gosset P, Sadofsky LR, Mariot P, Warnier M, Bokhobza A, Slomianny C, Mauroy B, Bonnal JL, Dewailly E, Delcourt P, Allart L, Desruelles E, Prevarskaya N, Roudbaraki M. Activation of mutated TRPA1 ion channel by resveratrol in human prostate cancer associated fibroblasts (CAF). Mol Carcinog 2017; 56:1851-1867. [PMID: 28277613 DOI: 10.1002/mc.22642] [Citation(s) in RCA: 35] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/26/2016] [Revised: 02/10/2017] [Accepted: 03/03/2017] [Indexed: 12/18/2022]
Abstract
Previous studies showed the effects of resveratrol (RES) on several cancer cells, including prostate cancer (PCa) cell apoptosis without taking into consideration the impact of the tumor microenvironment (TME). The TME is composed of cancer cells, endothelial cells, blood cells, and cancer-associated fibroblasts (CAF), the main source of growth factors. The latter cells might modify in the TME the impact of RES on tumor cells via secreted factors. Recent data clearly show the impact of CAF on cancer cells apoptosis resistance via secreted factors. However, the effects of RES on PCa CAF have not been studied so far. We have investigated here for the first time the effects of RES on the physiology of PCa CAF in the context of TME. Using a prostate cancer CAF cell line and primary cultures of CAF from prostate cancers, we show that RES activates the N-terminal mutated Transient Receptor Potential Ankyrin 1 (TRPA1) channel leading to an increase in intracellular calcium concentration and the expression and secretion of growth factors (HGF and VEGF) without inducing apoptosis in these cells. Interestingly, in the present work, we also show that when the prostate cancer cells were co-cultured with CAF, the RES-induced cancer cell apoptosis was reduced by 40%, an apoptosis reduction canceled in the presence of the TRPA1 channel inhibitors. The present work highlights CAF TRPA1 ion channels as a target for RES and the importance of the channel in the epithelial-stromal crosstalk in the TME leading to resistance to the RES-induced apoptosis.
Collapse
Affiliation(s)
- Eric Vancauwenberghe
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Lucile Noyer
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Sandra Derouiche
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Loïc Lemonnier
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Pierre Gosset
- Faculté Libre de Médecine, Laboratoire d'Anatomie et de Cytologie Pathologique du groupement hospitalier de l'Institut Catholique de Lille, Lille, France
| | - Laura R Sadofsky
- Cardiovascular and Respiratory Studies, The University of Hull, Castle Hill Hospital, Cottingham, United Kingdom
| | - Pascal Mariot
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Marine Warnier
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Alexandre Bokhobza
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Christian Slomianny
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Brigitte Mauroy
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Service d'Urologie de l'hôpital St-Philibert, Lille, France
| | - Jean-Louis Bonnal
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Service d'Urologie de l'hôpital St-Philibert, Lille, France
| | - Etienne Dewailly
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Philippe Delcourt
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Laurent Allart
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Emilie Desruelles
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Natalia Prevarskaya
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Morad Roudbaraki
- Univ. Lille, Inserm, U1003-PHYCEL-Physiologie Cellulaire, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, Lille, France.,Laboratory of Excellence, Ion Channels Science and Therapeutics, Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| |
Collapse
|
30
|
Bonnal JL, Marien A, ROCK A, El maadarani K, Mauroy B, Bessard D, Delebarre A, Gosset P, Blaire T. MP77-02 FIRST CLINICAL EXPERIENCE OF TRIMODAL (18)F-CHOLINE-PET/MPMRI/TRUS TARGETED PROSTATE BIOPSIES: A PILOT STUDY FOR A NEW CONCEPT. J Urol 2017. [DOI: 10.1016/j.juro.2017.02.2110] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/24/2022]
|
31
|
Marien A, Rock A, Maadarani KE, Francois C, Gosset P, Mauroy B, Bonnal JL. Urothelial Tumors and Dual-Band Imaging: A New Concept in Confocal Laser Endomicroscopy. J Endourol 2017; 31:538-544. [PMID: 28326794 DOI: 10.1089/end.2016.0892] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Abstract
OBJECTIVES Confocal laser endomicroscopy (CLE) uses a low-energy laser light source to obtain microscopic histology images of bladder tissue exposed to a fluorescent dye. To evaluate the feasibility of using CLE with two fluorophores: fluorescein (FLUO) and hexylaminolevulinate (HAL) to determine histologic and cytologic bladder cancer criteria. METHODS Patients eligible for HAL-photodynamic diagnosis-assisted transurethral resection of bladder tumor were included. The procedures were performed with the patient under regional or general anesthesia (60-90 minutes) after bladder instillation of HAL (50 mL, 8 mmol/L; Hexvix®; Ipsen, France). Resected tissue was examined ex vivo using CLE either with Cellvizio® system (CVI) single laser (488 nm) or with Cellvizio Dual system (CVII) double laser (488, 660 nm). RESULTS Twenty-one patients were included, 12 examined by CVI and 9 by CVII. Sample examination on CVI after HAL-CLE-only histologic analysis was not possible because HAL is mostly cytoplasmic and gives poor details on cellular architecture. On the contrary, FLUO-CLE gives good extracellular architecture and not clear information of nucleocytoplasmic abnormality. Samples on CVII for seven out of nine patients clearly showed cytoplasm of suspect cells and nuclei. In real time, fluorescence observed on bandwidth (673-800 nm) with HAL and FLUO was associated with the presence of cancer, with a sensibility and specificity of 80% and 100%, respectively. CONCLUSIONS Real-time cytodetection was feasible using two fluorophores (FLUO and HAL) and the new system of CVII. This technology was useful to observe cytoplasm, nuclei, and nucleocytoplasmic abnormality, but an improved system is necessary (to overcome the overlapping of fluorescence) to increase the specificity.
Collapse
Affiliation(s)
- Arnaud Marien
- 1 Department of Urology, Groupe Hospitalier de l'Institut Catholique Lillois , Faculté Libre de Médecine, Lille, France
| | - Aurélien Rock
- 1 Department of Urology, Groupe Hospitalier de l'Institut Catholique Lillois , Faculté Libre de Médecine, Lille, France
| | - Khaled El Maadarani
- 1 Department of Urology, Groupe Hospitalier de l'Institut Catholique Lillois , Faculté Libre de Médecine, Lille, France
| | - Catherine Francois
- 1 Department of Urology, Groupe Hospitalier de l'Institut Catholique Lillois , Faculté Libre de Médecine, Lille, France
| | - Pierre Gosset
- 2 Department of Pathology and Cytology, Groupe Hospitalier de l'Institut Catholique Lillois , Faculté Libre de Médecine, Lille, France
| | - Brigitte Mauroy
- 1 Department of Urology, Groupe Hospitalier de l'Institut Catholique Lillois , Faculté Libre de Médecine, Lille, France
| | - Jean-Louis Bonnal
- 1 Department of Urology, Groupe Hospitalier de l'Institut Catholique Lillois , Faculté Libre de Médecine, Lille, France
| |
Collapse
|
32
|
Porte R, Van Maele L, Muñoz-Wolf N, Foligné B, Dumoutier L, Tabareau J, Cayet D, Gosset P, Jonckheere N, Van Seuningen I, Chabalgoity JA, Simonet M, Lamkanfi M, Renauld JC, Sirard JC, Carnoy C. Flagellin-Mediated Protection against Intestinal Yersinia pseudotuberculosis Infection Does Not Require Interleukin-22. Infect Immun 2017; 85:e00806-16. [PMID: 27872237 PMCID: PMC5278166 DOI: 10.1128/iai.00806-16] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2016] [Accepted: 11/11/2016] [Indexed: 12/11/2022] Open
Abstract
Signaling through Toll-like receptors (TLRs), the main receptors in innate immunity, is essential for the defense of mucosal surfaces. It was previously shown that systemic TLR5 stimulation by bacterial flagellin induces an immediate, transient interleukin-22 (IL-22)-dependent antimicrobial response to bacterial or viral infections of the mucosa. This process was dependent on the activation of type 3 innate lymphoid cells (ILCs). The objective of the present study was to analyze the effects of flagellin treatment in a murine model of oral infection with Yersinia pseudotuberculosis (an invasive, Gram-negative, enteropathogenic bacterium that targets the small intestine). We found that systemic administration of flagellin significantly increased the survival rate after intestinal infection (but not systemic infection) by Y. pseudotuberculosis This protection was associated with a low bacterial count in the gut and the spleen. In contrast, no protection was afforded by administration of the TLR4 agonist lipopolysaccharide, suggesting the presence of a flagellin-specific effect. Lastly, we found that TLR5- and MyD88-mediated signaling was required for the protective effects of flagellin, whereas neither lymphoid cells nor IL-22 was involved.
Collapse
Affiliation(s)
- Rémi Porte
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR8204, CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Laurye Van Maele
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR8204, CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Natalia Muñoz-Wolf
- Laboratory for Vaccine Research, Department of Biotechnology, Instituto de Higiene, Facultad de Medicina, Universidad de la Republica, Montevideo, Uruguay
| | - Benoit Foligné
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR8204, CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Laure Dumoutier
- Ludwig Institute for Cancer Research, Brussels Branch, and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
| | - Julien Tabareau
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR8204, CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Delphine Cayet
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR8204, CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Pierre Gosset
- Hopital Saint Vincent, Groupe Hospitalier de l'Institut Catholique de Lille, Université Catholique de Lille, Lille, France
| | - Nicolas Jonckheere
- Univ. Lille, INSERM, CHU Lille, UMR-S 1172, JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, Lille, France
| | - Isabelle Van Seuningen
- Univ. Lille, INSERM, CHU Lille, UMR-S 1172, JPArc-Centre de Recherche Jean-Pierre Aubert Neurosciences et Cancer, Lille, France
| | - José A Chabalgoity
- Laboratory for Vaccine Research, Department of Biotechnology, Instituto de Higiene, Facultad de Medicina, Universidad de la Republica, Montevideo, Uruguay
| | - Michel Simonet
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR8204, CIIL-Center for Infection and Immunity of Lille, Lille, France
- Laboratoire de Bactériologie Hygiène, Institut de Microbiologie, Centre de Biologie Pathologie, CHRU Lille, Lille, France
| | - Mohamed Lamkanfi
- Department of Medical Protein Research, VIB, and Department of Biochemistry, Ghent University, Ghent, Belgium
| | - Jean-Christophe Renauld
- Ludwig Institute for Cancer Research, Brussels Branch, and de Duve Institute, Université Catholique de Louvain, Brussels, Belgium
| | - Jean-Claude Sirard
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR8204, CIIL-Center for Infection and Immunity of Lille, Lille, France
| | - Christophe Carnoy
- Univ. Lille, CNRS, INSERM, CHU Lille, Institut Pasteur de Lille, U1019-UMR8204, CIIL-Center for Infection and Immunity of Lille, Lille, France
| |
Collapse
|
33
|
Derouiche S, Mariot P, Warnier M, Vancauwenberghe E, Bidaux G, Gosset P, Mauroy B, Bonnal JL, Slomianny C, Delcourt P, Dewailly E, Prevarskaya N, Roudbaraki M. Activation of TRPA1 Channel by Antibacterial Agent Triclosan Induces VEGF Secretion in Human Prostate Cancer Stromal Cells. Cancer Prev Res (Phila) 2017; 10:177-187. [PMID: 28096238 DOI: 10.1158/1940-6207.capr-16-0257] [Citation(s) in RCA: 26] [Impact Index Per Article: 3.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/11/2016] [Revised: 12/30/2016] [Accepted: 01/03/2017] [Indexed: 11/16/2022]
Abstract
Accruing evidence indicates that exposure to environmental compounds may adversely affect human health and promote carcinogenesis. Triclosan (TCS), an antimicrobial agent widely used as a preservative in personal care products, has been shown to act as an endocrine disruptor in hormone-dependent tissues. Here, we demonstrate a new molecular mechanism by which TCS stimulates the secretion by human prostate cancer stromal cells of vascular endothelial growth factor (VEGF), a factor known to promote tumor growth. This mechanism involves an increase in intracellular calcium levels due to the direct activation of a membrane ion channel. Using calcium imaging and electrophysiology techniques, we show for the first time that environmentally relevant concentrations of TCS activate a cation channel of the TRP family, TRPA1 (Transient Receptor Potential Ankirin 1), in primary cultured human prostate cancer stromal cells. The TCS-induced TRPA1 activation increased basal calcium in stromal cells and stimulated the secretion of VEGF and epithelial cells proliferation. Interestingly, immunofluorescence labeling performed on formalin-fixed paraffin-embedded prostate tissues showed an exclusive expression of the TRPA1 channel in prostate cancer stromal cells. Our data demonstrate an impact of the environmental factor TCS on the tumor microenvironment interactions, by activating a tumor stroma-specific TRPA1 ion channel. Cancer Prev Res; 10(3); 177-87. ©2017 AACR.
Collapse
Affiliation(s)
- Sandra Derouiche
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Pascal Mariot
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Marine Warnier
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Eric Vancauwenberghe
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Gabriel Bidaux
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Pierre Gosset
- Département de Pathologies, Laboratoire d'Anatomie et de Cytologie Pathologique, Groupe Hospitalier de l'Institut Catholique de Lille (GHICL), Lille, France
| | - Brigitte Mauroy
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
- Service d'Urologie de l'hôpital St-Philibert, Lomme, France
| | - Jean-Louis Bonnal
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
- Service d'Urologie de l'hôpital St-Philibert, Lomme, France
| | - Christian Slomianny
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Philippe Delcourt
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Etienne Dewailly
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Natalia Prevarskaya
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France
| | - Morad Roudbaraki
- Univ. Lille, Inserm, U1003 - PHYCEL - Physiologie Cellulaire, F-59000 Lille, Equipe labellisée par la Ligue Nationale contre le cancer, Villeneuve d'Ascq, France; Laboratory of Excellence, Ion Channels Science and Therapeutics; Université Lille I Sciences et Technologies, Villeneuve d'Ascq, France.
| |
Collapse
|
34
|
Sharan R, Perez-Cruz M, Kervoaze G, Gosset P, Weynants V, Godfroid F, Hermand P, Trottein F, Pichavant M, Gosset P. Interleukin-22 protects against non-typeable Haemophilus influenzae infection: alteration during chronic obstructive pulmonary disease. Mucosal Immunol 2017; 10:139-149. [PMID: 27143304 DOI: 10.1038/mi.2016.40] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/28/2015] [Accepted: 03/24/2016] [Indexed: 02/04/2023]
Abstract
Chronic obstructive pulmonary disease is a major health problem becoming a leading cause of morbidity and mortality worldwide. A large part of these disorders is associated with acute exacerbations resulting from infection by bacteria, such as non-typeable Haemophilus influenzae (NTHi). Our understanding of the pathogenesis of these exacerbations is still elusive. We demonstrate herein that NTHi infection of mice chronically exposed to cigarette smoke (CS), an experimental model of chronic obstructive pulmonary disease (COPD), not only causes acute pulmonary inflammation but also impairs the production of interleukin (IL)-22, a cytokine with potential anti-bacterial activities. We also report that mice lacking IL-22, as well as mice exposed to CS, have a delayed clearance of NTHi bacteria and display enhanced alveolar wall thickening and airway remodeling compared with controls. Supplementation with IL-22 not only boosted bacterial clearance and the production of anti-microbial peptides but also limited lung damages induced by infection both in IL-22-/- and CS-exposed mice. In vitro exposure to CS extract altered the NTHi-induced IL-22 production by spleen cells. This study shows for the first time that a defect in IL-22 is involved in the acute exacerbation induced by NTHi infection during experimental COPD and opens the way to innovative therapeutic strategies.
Collapse
Affiliation(s)
- R Sharan
- Université Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France
- CNRS, UMR 8204, Lille, France
- Inserm, U1019, Lille, France
- CHU Lille, Lille, France
- Institut Pasteur de Lille, Lille, France
| | - M Perez-Cruz
- Université Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France
- CNRS, UMR 8204, Lille, France
- Inserm, U1019, Lille, France
- CHU Lille, Lille, France
- Institut Pasteur de Lille, Lille, France
| | - G Kervoaze
- Université Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France
- CNRS, UMR 8204, Lille, France
- Inserm, U1019, Lille, France
- CHU Lille, Lille, France
- Institut Pasteur de Lille, Lille, France
| | - Pierre Gosset
- Service d'Anatomo-pathologie, Hôpital Saint Vincent de Paul, Lille, France
| | | | | | | | - F Trottein
- Université Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France
- CNRS, UMR 8204, Lille, France
- Inserm, U1019, Lille, France
- CHU Lille, Lille, France
- Institut Pasteur de Lille, Lille, France
| | - M Pichavant
- Université Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France
- CNRS, UMR 8204, Lille, France
- Inserm, U1019, Lille, France
- CHU Lille, Lille, France
- Institut Pasteur de Lille, Lille, France
| | - P Gosset
- Université Lille, U1019 - UMR 8204 - CIIL - Centre d'Infection et d'Immunité de Lille, Lille, France
- CNRS, UMR 8204, Lille, France
- Inserm, U1019, Lille, France
- CHU Lille, Lille, France
- Institut Pasteur de Lille, Lille, France
| |
Collapse
|
35
|
Héliot A, Landkocz Y, Roy Saint-Georges F, Gosset P, Billet S, Shirali P, Courcot D, Martin PJ. Smoker extracellular vesicles influence status of human bronchial epithelial cells. Int J Hyg Environ Health 2016; 220:445-454. [PMID: 28063900 DOI: 10.1016/j.ijheh.2016.12.010] [Citation(s) in RCA: 21] [Impact Index Per Article: 2.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2016] [Revised: 12/09/2016] [Accepted: 12/23/2016] [Indexed: 12/17/2022]
Abstract
Cigarette smoking is a habit that has spread all over the world and is a significant risk factor for many diseases including cardiovascular disease, chronic obstructive pulmonary disease (COPD), asthma and lung cancer. Evaluation and understanding of tobacco health effects are of major interest worldwide and answer to important societal concerns. Identification of new biomarkers of exposure to tobacco smoke potentially implicated in COPD or lung carcinogenesis would allow a better observation of tobacco exposed population, thanks to screening establishment at reversible stages of pathological processes. In this study, we questioned whether cigarette smoking alters miRNA profiles of Extracellular Vesicles (EVs) present in human Broncho Alveolar Lavages (BALs), which could affect surrounding normal bronchial epithelial cells status. To this aim, BALs were carried out on 10 Smokers and 10 Non-Smokers, and EVs were isolated from the supernatants and characterized. We then compared the amount of 10 microRNAs (miRNAs) present in Smokers versus Non-Smokers BAL EVs and performed statistical analysis to discuss the biological significance by the smoking status and to evaluate BAL EV miRNAs as potential biomarkers of tobacco exposure. Finally, we tested the effects of smokers versus non-smokers EVs on human bronchial epithelial cells (BEAS-2B) to compare their influence on the cells status. Our study shows for the first time in human samples that smoking can alter lung EV profile that can influence surrounding bronchial epithelial cells.
Collapse
Affiliation(s)
- Amélie Héliot
- Unité de Chimie Environnementale et Interactions sur le Vivant (UCEIV), EA4492, Université du Littoral Côte d'Opale (ULCO), Dunkerque, France.
| | - Yann Landkocz
- Unité de Chimie Environnementale et Interactions sur le Vivant (UCEIV), EA4492, Université du Littoral Côte d'Opale (ULCO), Dunkerque, France.
| | | | - Pierre Gosset
- Anatomo-pathology service, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille, France.
| | - Sylvain Billet
- Unité de Chimie Environnementale et Interactions sur le Vivant (UCEIV), EA4492, Université du Littoral Côte d'Opale (ULCO), Dunkerque, France.
| | - Pirouz Shirali
- Unité de Chimie Environnementale et Interactions sur le Vivant (UCEIV), EA4492, Université du Littoral Côte d'Opale (ULCO), Dunkerque, France.
| | - Dominique Courcot
- Unité de Chimie Environnementale et Interactions sur le Vivant (UCEIV), EA4492, Université du Littoral Côte d'Opale (ULCO), Dunkerque, France.
| | - Perrine J Martin
- Unité de Chimie Environnementale et Interactions sur le Vivant (UCEIV), EA4492, Université du Littoral Côte d'Opale (ULCO), Dunkerque, France.
| |
Collapse
|
36
|
Kalach N, Gosset P, Dehecq E, Decoster A, Papadopolo S, Spyckerelle C, Dupont C, Raymond J. Test rapide d’antigène dans le selles dans le diagnostic de l’infection à Helicobacter pylori en pédiatrie. Arch Pediatr 2016. [DOI: 10.1016/j.arcped.2016.09.042] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
37
|
Gräsner JT, Lefering R, Koster RW, Masterson S, Böttiger BW, Herlitz J, Wnent J, Tjelmeland IB, Ortiz FR, Maurer H, Baubin M, Mols P, HadžibegoviĿ I, Ioannides M, Škulec R, Wissenberg M, Salo A, Hubert H, Nikolaou NI, Lóczi G, Svavarsdóttir H, Semeraro F, Wright PJ, Clarens C, Pijls R, Cebula G, Correia VG, Cimpoesu D, Raffay V, Trenkler S, Markota A, Strömsöe A, Burkart R, Perkins GD, Bossaert LL, Kaufmann M, Thaler M, Maier M, Prause G, Trimmel H, de Longueville D, Preseau T, Biarent D, Melot C, Mpotos N, Monsieurs K, Van de Voorde P, Vanhove M, Lievens P, Faniel M, Keleuva S, Lazarevic M, Ujevic RM, Devcic M, Bardak B, Barisic F, Anticevic SH, Georgiou M, Truhláſ A, Knor J, Smržová E, Sviták R, Šín R, Mokrejš P, Lippert FK, Hallikainen J, Hoikka M, Iirola T, Jama T, Jäntti H, Jokisalo R, Jousi M, Kirves H, Kuisma M, Laine J, Länkimäki S, Loikas P, Lund V, Määttä T, Nal H, Niemelä H, Portaankorva P, Pylkkänen M, Sainio M, Setälä P, Tervo J, Väyrynen T, Jama T, Murgue D, Champenois A, Fournier M, Meyran D, Tabary R, Avondo A, Gelin G, Simonnet B, Joly M, Megy-Michoux I, Paringaux X, Duffait Y, Vial M, Segard J, Narcisse S, Hamban D, Hennache J, Thiriez S, Doukhan M, Vanderstraeten C, Morel JC, Majour G, Michenet C, Tritsch L, Dubesset M, Peguet O, Pinero D, Guillaumee F, Fuster P, Ciacala JF, Jardel B, Letarnec JY, Goes F, Gosset P, Vergne M, Bar C, Branche F, Prineau S, Lagadec S, Cornaglia C, Ursat C, Bertrand P, Agostinucci JM, Nadiras P, de Linares GG, Jacob L, Revaux F, Pernot T, Roudiak N, Ricard-Hibon A, Villain-Coquet L, Beckers S, Hanff T, Strickmann B, Wiegand N, Wilke P, Sues H, Bogatzki S, Baumeier W, Pohl K, Werner B, Fischer H, Zeng T, Popp E, Günther A, Hochberg A, Lechleuthner A, Schewe JC, Lemke H, Wranze-Bielefeld E, Bohn A, Roessler M, Naujoks F, Sensen F, Esser T, Fischer M, Messelken M, Rose C, Schlüter G, Lotz W, Corzilius M, Muth CM, Diepenseifen C, Tauchmann B, Birkholz T, Flemming A, Herrmann S, Kreimeier U, Kill C, Marx F, Schröder R, Lenz W, Botini G, Grigorios B, Giannakoudakis N, Zervopoulos M, Papangelis D, Petropoulou-Papanastasiou S, Liaskos T, Papanikolaou S, Karabinis A, Zentay A, ÿorsteinsson H, Gilsdóttir A, Birgisson SA, Guðmundsson FF, Hreiðarsson H, ÿrnason B, Hermannsson H, Björnsson G, Friðriksson BŸ, Baldursson G, Höskuldsson Ÿ, Valgarðsdottir J, ÿsmundardóttir M, Guðmundsson G, Kristjánsson H, ÿórarinsson ER, Guðlaugsson J, Skarphéðinsson S, Peratoner A, Santarelli A, Sabetta C, Gordini G, Sesana G, Giudici R, Savastano S, Pellis T, Beissel J, Uhrig J, Manderscheid T, Klop M, Stammet P, Koch M, Welter P, Schuman R, Bruins W, Amin H, Braa N, Bratland S, Buanes EA, Draegni T, Johnsen KR, Mathisen WT, Oedegaarden T, Oppedal M, Reksten ASN, Roedsand ME, Steen-Hansen JE, Dyrda M, Frejlich A, MaciĿg S, Osadnik S, Weryk I, Mendonça E, Freitas C, Cruz P, Caldeira C, Barros J, Vale L, Brazão A, Jardim N, Rocha F, Duarte R, Fernandes N, Ramos P, Jardim M, Reis M, Ribeiro R, Zenha S, Fernandes J, Francisco J, Assis D, Abreu F, Freitas D, Ribeiro L, Azevedo P, Calafatinho D, Jardim R, Pestana A, Faria R, Oprita B, Grasu A, Nedelea P, Sovar S, Agapi F, KliĿkoviĿ A, LaziĿ A, NikoliĿ B, Zivanovic B, MartinoviĿ B, MilenkoviĿ D, Damir H, Koprivica J, JakšiĿ KH, Pajor M, MiliĿ S, VidoviĿ M, Glamoclija RP, Andjelic S, Sladjana V, BabiĿ Z, Fišer Z, Androvic P, Bajerovska L, Chabron M, Dobias V, Havlikova E, Horanova B, Kratochvilova R, Kubova D, Murgas J, Patras J, Simak L, Snarskij V, Zaviaticova Z, Zuffova M, Roig FE, Santos LS, Sucunza AE, Cordero Torres JA, Muñoz GI, del Valle MM, Rozalen IC, Sánchez EM, Berlanga MVRC, Olalde KI, Ruiz Azpiazu JI, García-Ochoa MJ, López-Navarro RZ, Adsuar Quesada JM, Cortés Ramas JA, Mellado Vergel FJ, López Messa JB, del Valle PF, Anselmi L, Benvenuti BC, Batey N, Ambulance Y, Booth S, Bucher P, Deakin CD, Duckett J, Ji C, Loughlin N, Lumley-Holmes J, Lynde J, Mersom F, Ramsey C, Robinson C, Spaight R, Dosanjh S, Virdi G, Whittington A. EuReCa ONE27 Nations, ONE Europe, ONE Registry. Resuscitation 2016; 105:188-95. [DOI: 10.1016/j.resuscitation.2016.06.004] [Citation(s) in RCA: 334] [Impact Index Per Article: 41.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/19/2016] [Revised: 05/31/2016] [Accepted: 06/08/2016] [Indexed: 10/21/2022]
|
38
|
Tellier G, Lenne A, Cailliau-Maggio K, Cabezas-Cruz A, Valdés JJ, Martoriati A, Aliouat EM, Gosset P, Delaire B, Fréville A, Pierrot C, Khalife J. Identification of Plasmodium falciparum Translation Initiation eIF2β Subunit: Direct Interaction with Protein Phosphatase Type 1. Front Microbiol 2016; 7:777. [PMID: 27303372 PMCID: PMC4881399 DOI: 10.3389/fmicb.2016.00777] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/14/2016] [Accepted: 05/09/2016] [Indexed: 12/19/2022] Open
Abstract
Protein phosphatase 1 (PP1c) is one of the main phosphatases whose function is shaped by many regulators to confer a specific location and a selective function for this enzyme. Here, we report that eukaryotic initiation factor 2β of Plasmodium falciparum (PfeIF2β) is an interactor of PfPP1c. Sequence analysis of PfeIF2β revealed a deletion of 111 amino acids when compared to its human counterpart and the presence of two potential binding motifs to PfPP1 (29FGEKKK34, 103KVAW106). As expected, we showed that PfeIF2β binds PfeIF2γ and PfeIF5, confirming its canonical interaction with partners of the translation complex. Studies of the PfeIF2β-PfPP1 interaction using wild-type, single and double mutated versions of PfeIF2β revealed that both binding motifs are critical. We next showed that PfeIF2β is able to induce Germinal Vesicle Break Down (GVBD) when expressed in Xenopus oocytes, an indicator of its capacity to regulate PP1. Only combined mutations of both binding motifs abolished the interaction with PP1 and the induction of GVBD. In P. falciparum, although the locus is accessible for genetic manipulation, PfeIF2β seems to play an essential role in intraerythrocytic cycle as no viable knockout parasites were detectable. Interestingly, as for PfPP1, the subcellular fractionation of P. falciparum localized PfeIF2β in cytoplasm and nuclear extracts, suggesting a potential effect on PfPP1 in both compartments and raising the question of a non-canonical function of PfeIf2β in the nucleus. Hence, the role played by PfeIF2β in blood stage parasites could occur at multiple levels involving the binding to proteins of the translational complex and to PfPP1.
Collapse
Affiliation(s)
- Géraldine Tellier
- Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - Centre d'Infection et d'Immunité de Lille, Université de Lille Lille, France
| | - Astrid Lenne
- Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - Centre d'Infection et d'Immunité de Lille, Université de Lille Lille, France
| | - Katia Cailliau-Maggio
- Centre National de la Recherche Scientifique, UMR 8576 - Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille Lille, France
| | - Alejandro Cabezas-Cruz
- Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - Centre d'Infection et d'Immunité de Lille, Université de Lille Lille, France
| | - James J Valdés
- Institute of Parasitology, The Czech Academy of SciencesČeské Budějovice, Czech Republic; Department of Virology, Veterinary Research InstituteBrno, Czech Republic
| | - Alain Martoriati
- Centre National de la Recherche Scientifique, UMR 8576 - Unité de Glycobiologie Structurale et Fonctionnelle, Université de Lille Lille, France
| | - El M Aliouat
- Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - Centre d'Infection et d'Immunité de Lille, Université de Lille Lille, France
| | - Pierre Gosset
- Service d'Anatomie et de Cytologie Pathologiques, Groupe Hospitalier de l'Université Catholique de Lille Lille, France
| | - Baptiste Delaire
- Service d'Anatomie et de Cytologie Pathologiques, Groupe Hospitalier de l'Université Catholique de Lille Lille, France
| | - Aline Fréville
- Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - Centre d'Infection et d'Immunité de Lille, Université de Lille Lille, France
| | - Christine Pierrot
- Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - Centre d'Infection et d'Immunité de Lille, Université de Lille Lille, France
| | - Jamal Khalife
- Centre National de la Recherche Scientifique, Institut National de la Santé et de la Recherche Médicale, CHU Lille, Institut Pasteur de Lille, U1019 - UMR 8204 - Centre d'Infection et d'Immunité de Lille, Université de Lille Lille, France
| |
Collapse
|
39
|
Abbas I, Verdin A, Escande F, Saint-Georges F, Cazier F, Mulliez P, Courcot D, Shirali P, Gosset P, Garçon G. In vitro short-term exposure to air pollution PM2.5-0.3 induced cell cycle alterations and genetic instability in a human lung cell coculture model. Environ Res 2016; 147:146-158. [PMID: 26874047 DOI: 10.1016/j.envres.2016.01.041] [Citation(s) in RCA: 19] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/19/2015] [Revised: 01/25/2016] [Accepted: 01/27/2016] [Indexed: 06/05/2023]
Abstract
Although its adverse health effects of air pollution particulate matter (PM2.5) are well-documented and often related to oxidative stress and pro-inflammatory response, recent evidence support the role of the remodeling of the airway epithelium involving the regulation of cell death processes. Hence, the overarching goals of the present study were to use an in vitro coculture model, based on human AM and L132 cells to study the possible alteration of TP53-RB gene signaling pathways (i.e. cell cycle phases, gene expression of TP53, BCL2, BAX, P21, CCND1, and RB, and protein concentrations of their active forms), and genetic instability (i.e. LOH and/or MSI) in the PM2.5-0.3-exposed coculture model. PM2.5-0.3 exposure of human AM from the coculture model induced marked cell cycle alterations after 24h, as shown by increased numbers of L132 cells in subG1 and S+G2 cell cycle phases, indicating apoptosis and proliferation. Accordingly, activation of the TP53-RB gene signaling pathways after the coculture model exposure to PM2.5-0.3 was reported in the L132 cells. Exposure of human AM from the coculture model to PM2.5-0.3 resulted in MS alterations in 3p chromosome multiple critical regions in L132 cell population. Hence, in vitro short-term exposure of the coculture model to PM2.5-0.3 induced cell cycle alterations relying on the sequential occurrence of molecular abnormalities from TP53-RB gene signaling pathway activation and genetic instability.
Collapse
Affiliation(s)
- Imane Abbas
- Université de Lille, Lille, France; EA4492-UCEIV, Université du Littoral-Côte d'Opale, Dunkerque, France; Lebanese Atomic Energy Commission - CNRS, Beirut, Lebanon
| | - Anthony Verdin
- Université de Lille, Lille, France; EA4492-UCEIV, Université du Littoral-Côte d'Opale, Dunkerque, France
| | - Fabienne Escande
- Centre de Biologie Pathologie, Centre Hospitalier Régional et Universitaire, Lille, France
| | - Françoise Saint-Georges
- Université de Lille, Lille, France; Groupement Hospitalier de l'Institut Catholique de Lille, Lille, France
| | - Fabrice Cazier
- Université de Lille, Lille, France; Centre Commun de Mesures, Université du Littoral-Côte d'Opale, Dunkerque, France
| | - Philippe Mulliez
- Université de Lille, Lille, France; Groupement Hospitalier de l'Institut Catholique de Lille, Lille, France
| | - Dominique Courcot
- Université de Lille, Lille, France; EA4492-UCEIV, Université du Littoral-Côte d'Opale, Dunkerque, France
| | - Pirouz Shirali
- Université de Lille, Lille, France; EA4492-UCEIV, Université du Littoral-Côte d'Opale, Dunkerque, France
| | - Pierre Gosset
- Université de Lille, Lille, France; Groupement Hospitalier de l'Institut Catholique de Lille, Lille, France
| | - Guillaume Garçon
- Université de Lille, Lille, France; EA4492-UCEIV, Université du Littoral-Côte d'Opale, Dunkerque, France; EA4483-IMPECS, Université de Lille 2, Lille, France.
| |
Collapse
|
40
|
Rossez Y, Burtea C, Laurent S, Gosset P, Léonard R, Gonzalez W, Ballet S, Raynal I, Rousseaux O, Dugué T, Vander Elst L, Michalski JC, Muller RN, Robbe-Masselot C. Early detection of colonic dysplasia by magnetic resonance molecular imaging with a contrast agent raised against the colon cancer marker MUC5AC. Contrast Media Mol Imaging 2016; 11:211-21. [PMID: 26762591 DOI: 10.1002/cmmi.1682] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 06/01/2015] [Revised: 10/08/2015] [Accepted: 11/27/2015] [Indexed: 11/05/2022]
Abstract
Human gastric mucin MUC5AC is secreted in the colonic mucus of cancer patients and is a specific marker of precancerous lesions called aberrant crypt foci. Using MUC5AC as a specific marker can improve sensitivity in the detection of early colorectal cancer. Here we demonstrated that the accumulation of MUC5AC in xenograft and mouse stomach can be detected by magnetic resonance imaging (MRI). We used ultrasmall particles of iron oxide (USPIOs) conjugated with disulfide constrained heptapeptide that were identified using a screening phage display. To accomplish this, we employed positive selection of the phage display library on MUC5AC purified from fresh human colonic adenomas in combination with negative selection of the phage library on purified human MUC2, which is predominantly found in normal colorectal tissues. This conjugate was tested on human colorectal cancer cell lines that were either able or unable to secrete MUC5AC, both in vitro and in vivo. MUC5AC-USPIO contrast agent and USPIOs alone were not detected in cell lines unable to secrete MUC5AC. A combination of MRI and microscopy studies was performed to detect a specific accumulation of the contrast agent in vivo. Thus, the MUC5AC contrast agent enabled non-invasive detection of precancerous lesions and colorectal cancer, highlighting its potential use in diagnostics, in the early detection of colorectal cancer recurrences after treatment and in mechanistic studies implicating MUC5AC. Copyright © 2016 John Wiley & Sons, Ltd.
Collapse
Affiliation(s)
- Yannick Rossez
- University of Lille Nord de France, F-59000, Lille, France.,USTL, UGSF, IFR 147, F-59650, Villeneuve d'Ascq, France.,CNRS, UMR 8576, F-59650, Villeneuve d'Ascq, France
| | - Carmen Burtea
- Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons-Hainaut, 19, Avenue Maistriau, Mendeleev Building, B-7000, Mons, Belgium
| | - Sophie Laurent
- Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons-Hainaut, 19, Avenue Maistriau, Mendeleev Building, B-7000, Mons, Belgium
| | - Pierre Gosset
- University of Lille Nord de France, F-59000, Lille, France.,UCLille, Service d'Anatomie Pathologie, F-59000, Lille, France.,Groupe Hospitalier de l'Institut Catholique Lillois/Faculté Libre de Médecine, F-59000, Lille, France
| | - Renaud Léonard
- University of Lille Nord de France, F-59000, Lille, France.,USTL, UGSF, IFR 147, F-59650, Villeneuve d'Ascq, France.,CNRS, UMR 8576, F-59650, Villeneuve d'Ascq, France
| | - Walter Gonzalez
- Guerbet, Research Center, 16-24 rue Jean Chaptal, 93600, Aulnay-sous-Bois, France
| | - Sébastien Ballet
- Guerbet, Research Center, 16-24 rue Jean Chaptal, 93600, Aulnay-sous-Bois, France
| | - Isabelle Raynal
- Guerbet, Research Center, 16-24 rue Jean Chaptal, 93600, Aulnay-sous-Bois, France
| | - Olivier Rousseaux
- Guerbet, Research Center, 16-24 rue Jean Chaptal, 93600, Aulnay-sous-Bois, France
| | - Timothée Dugué
- Groupe Hospitalier de l'Institut Catholique Lillois/Faculté Libre de Médecine, F-59000, Lille, France
| | - Luce Vander Elst
- Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons-Hainaut, 19, Avenue Maistriau, Mendeleev Building, B-7000, Mons, Belgium
| | - Jean-Claude Michalski
- University of Lille Nord de France, F-59000, Lille, France.,USTL, UGSF, IFR 147, F-59650, Villeneuve d'Ascq, France.,CNRS, UMR 8576, F-59650, Villeneuve d'Ascq, France
| | - Robert N Muller
- Department of General, Organic and Biomedical Chemistry, NMR and Molecular Imaging Laboratory, University of Mons-Hainaut, 19, Avenue Maistriau, Mendeleev Building, B-7000, Mons, Belgium
| | - Catherine Robbe-Masselot
- University of Lille Nord de France, F-59000, Lille, France.,USTL, UGSF, IFR 147, F-59650, Villeneuve d'Ascq, France.,CNRS, UMR 8576, F-59650, Villeneuve d'Ascq, France
| |
Collapse
|
41
|
Pichavant M, Sharan R, Le Rouzic O, Olivier C, Hennegrave F, Rémy G, Pérez-Cruz M, Koné B, Gosset P, Just N, Gosset P. IL-22 Defect During Streptococcus pneumoniae Infection Triggers Exacerbation of Chronic Obstructive Pulmonary Disease. EBioMedicine 2015; 2:1686-96. [PMID: 26870795 PMCID: PMC4740310 DOI: 10.1016/j.ebiom.2015.09.040] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/04/2015] [Revised: 09/22/2015] [Accepted: 09/23/2015] [Indexed: 12/22/2022] Open
Abstract
Progression of chronic obstructive pulmonary disease (COPD) is linked to episodes of exacerbations caused by bacterial infections due to Streptococcus pneumoniae. Our objective was to identify during COPD, factors of susceptibility to bacterial infections among cytokine network and their role in COPD exacerbations. S. pneumoniae was used to sub-lethally challenge mice chronically exposed to air or cigarette smoke (CS) and to stimulate peripheral blood mononuclear cells (PBMC) from non-smokers, smokers and COPD patients. The immune response and the cytokine production were evaluated. Delayed clearance of the bacteria and stronger lung inflammation observed in infected CS-exposed mice were associated with an altered production of IL-17 and IL-22 by innate immune cells. This defect was related to a reduced production of IL-1β and IL-23 by antigen presenting cells. Importantly, supplementation with recombinant IL-22 restored bacterial clearance in CS-exposed mice and limited lung alteration. In contrast with non-smokers, blood NK and NKT cells from COPD patients failed to increase IL-17 and IL-22 levels in response to S. pneumoniae, in association with a defect in IL-1β and IL-23 secretion. This study identified IL-17 and IL-22 as susceptibility factors in COPD exacerbation. Therefore targeting such cytokines could represent a potent strategy to control COPD exacerbation.
Collapse
Key Words
- AM, alveolar macrophages
- APC, antigen presenting cells
- BAL, broncho-alveolar lavage
- Bacterial infection
- CFU, colony forming unit
- COPD, chronic obstructive pulmonary disease
- CS, cigarette smoke
- Chronic obstructive pulmonary disease
- DC, dendritic cells
- IL-22
- Innate immunity
- NK, natural killer cells
- NKT, natural killer T cells
- PBMC, peripheral blood mononuclear cells
- Sp, Streptococcus pneumoniae
Collapse
Affiliation(s)
- Muriel Pichavant
- Institut Pasteur de Lille, Centre d'Infection et d'Immunité de Lille, F-59019 Lille, France
- Université Lille Nord de France, F-59000 Lille, France
- Centre National de la Recherche Scientifique, UMR 8204, F-59021 Lille, France
- Institut National de la Santé et de la Recherche Médicale, U1019, F-59019 Lille, France
- Institut Fédératif de Recherche 142, F-59019 Lille, France
| | - Riti Sharan
- Institut Pasteur de Lille, Centre d'Infection et d'Immunité de Lille, F-59019 Lille, France
- Université Lille Nord de France, F-59000 Lille, France
- Centre National de la Recherche Scientifique, UMR 8204, F-59021 Lille, France
- Institut National de la Santé et de la Recherche Médicale, U1019, F-59019 Lille, France
- Institut Fédératif de Recherche 142, F-59019 Lille, France
| | - Olivier Le Rouzic
- Institut Pasteur de Lille, Centre d'Infection et d'Immunité de Lille, F-59019 Lille, France
- Université Lille Nord de France, F-59000 Lille, France
- Centre National de la Recherche Scientifique, UMR 8204, F-59021 Lille, France
- Institut National de la Santé et de la Recherche Médicale, U1019, F-59019 Lille, France
- Institut Fédératif de Recherche 142, F-59019 Lille, France
- Service de Pneumologie, Hôpital Calmette, CHRU, Lille, France
| | - Cécile Olivier
- Institut Pasteur de Lille, Centre d'Infection et d'Immunité de Lille, F-59019 Lille, France
- Université Lille Nord de France, F-59000 Lille, France
- Centre National de la Recherche Scientifique, UMR 8204, F-59021 Lille, France
- Institut National de la Santé et de la Recherche Médicale, U1019, F-59019 Lille, France
- Institut Fédératif de Recherche 142, F-59019 Lille, France
- Service de Pneumologie, Hôpital Calmette, CHRU, Lille, France
| | - Florence Hennegrave
- Institut Pasteur de Lille, Centre d'Infection et d'Immunité de Lille, F-59019 Lille, France
- Université Lille Nord de France, F-59000 Lille, France
- Centre National de la Recherche Scientifique, UMR 8204, F-59021 Lille, France
- Institut National de la Santé et de la Recherche Médicale, U1019, F-59019 Lille, France
- Institut Fédératif de Recherche 142, F-59019 Lille, France
- Service de Pneumologie, Hôpital Calmette, CHRU, Lille, France
| | - Gaëlle Rémy
- Institut Pasteur de Lille, Centre d'Infection et d'Immunité de Lille, F-59019 Lille, France
- Université Lille Nord de France, F-59000 Lille, France
- Centre National de la Recherche Scientifique, UMR 8204, F-59021 Lille, France
- Institut National de la Santé et de la Recherche Médicale, U1019, F-59019 Lille, France
- Institut Fédératif de Recherche 142, F-59019 Lille, France
| | - Magdiel Pérez-Cruz
- Institut Pasteur de Lille, Centre d'Infection et d'Immunité de Lille, F-59019 Lille, France
- Université Lille Nord de France, F-59000 Lille, France
- Centre National de la Recherche Scientifique, UMR 8204, F-59021 Lille, France
- Institut National de la Santé et de la Recherche Médicale, U1019, F-59019 Lille, France
- Institut Fédératif de Recherche 142, F-59019 Lille, France
| | - Bachirou Koné
- Institut Pasteur de Lille, Centre d'Infection et d'Immunité de Lille, F-59019 Lille, France
- Université Lille Nord de France, F-59000 Lille, France
- Centre National de la Recherche Scientifique, UMR 8204, F-59021 Lille, France
- Institut National de la Santé et de la Recherche Médicale, U1019, F-59019 Lille, France
- Institut Fédératif de Recherche 142, F-59019 Lille, France
| | - Pierre Gosset
- Service d'Anatomo-Pathologie, Hôpital Saint Vincent de Paul, Lille, France
| | - Nicolas Just
- Service de Pneumologie, Hôpital Victor Provo, Roubaix, France
| | - Philippe Gosset
- Institut Pasteur de Lille, Centre d'Infection et d'Immunité de Lille, F-59019 Lille, France
- Université Lille Nord de France, F-59000 Lille, France
- Centre National de la Recherche Scientifique, UMR 8204, F-59021 Lille, France
- Institut National de la Santé et de la Recherche Médicale, U1019, F-59019 Lille, France
- Institut Fédératif de Recherche 142, F-59019 Lille, France
| |
Collapse
|
42
|
Mihalache A, Delplanque JF, Ringot-Destrez B, Wavelet C, Gosset P, Nunes B, Groux-Degroote S, Léonard R, Robbe-Masselot C. Structural Characterization of Mucin O-Glycosylation May Provide Important Information to Help Prevent Colorectal Tumor Recurrence. Front Oncol 2015; 5:217. [PMID: 26500890 PMCID: PMC4597131 DOI: 10.3389/fonc.2015.00217] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2015] [Accepted: 09/22/2015] [Indexed: 12/18/2022] Open
Abstract
Although colorectal cancer is a preventable and curable disease if early stage tumors are removed, it still represents the second cause of cancer-related death worldwide. Surgical resection is the only curative treatment but once operated the patient is either subjected to adjuvant chemotherapy or not, depending on the invasiveness of the cancer and risks of recurrence. In this context, we investigated, by mass spectrometry (MS), alterations in the repertoire of glycosylation of mucins from colorectal tumors of various stages, grades, and recurrence status. Tumors were also compared with their counterparts in resection margins from the same patients and with healthy controls. The obtained data showed an important decrease in the level of expression of sialylated core 3-based O-glycans in tumors correlated with an increase in sialylated core 1 structures. No correlation was established between stages of the tumor samples and mucin O-glycosylation. However, with the notable exception of sialyl Tn antigens, tumors with recurrence presented a milder alteration of glycosylation profile than tumors without recurrence. These results suggest that mucin O-glycans from tumors with recurrence might mimic a healthier physiological situation, hence deceiving the immune defense system.
Collapse
Affiliation(s)
- Adriana Mihalache
- Structural and Functional Glycobiology Unit, UMR CNRS 8576, University of Lille , Villeneuve d'Ascq , France ; Service d'Anatomie Pathologie, Faculté Libre de Médecine, Hôpital Saint Vincent de Paul, Groupement des Hôpitaux de l'Institut Catholique de Lille , Lille , France
| | - Jean-François Delplanque
- Structural and Functional Glycobiology Unit, UMR CNRS 8576, University of Lille , Villeneuve d'Ascq , France
| | - Bélinda Ringot-Destrez
- Structural and Functional Glycobiology Unit, UMR CNRS 8576, University of Lille , Villeneuve d'Ascq , France
| | - Cindy Wavelet
- Structural and Functional Glycobiology Unit, UMR CNRS 8576, University of Lille , Villeneuve d'Ascq , France
| | - Pierre Gosset
- Service d'Anatomie Pathologie, Faculté Libre de Médecine, Hôpital Saint Vincent de Paul, Groupement des Hôpitaux de l'Institut Catholique de Lille , Lille , France
| | - Bertrand Nunes
- Service Chirurgie Digestive, Faculté Libre de Médecine, Hôpital Saint Philibert, Groupement des Hôpitaux de l'Institut Catholique de Lille , Lille , France
| | - Sophie Groux-Degroote
- Structural and Functional Glycobiology Unit, UMR CNRS 8576, University of Lille , Villeneuve d'Ascq , France
| | - Renaud Léonard
- Structural and Functional Glycobiology Unit, UMR CNRS 8576, University of Lille , Villeneuve d'Ascq , France
| | - Catherine Robbe-Masselot
- Structural and Functional Glycobiology Unit, UMR CNRS 8576, University of Lille , Villeneuve d'Ascq , France
| |
Collapse
|
43
|
Landkocz Y, Gosset P, Heliot A, Corbiere C, Vendeville C, Kevarec V, Billet S, Verdin A, Monteil C, Preterre D, Morin JP, Sichel F, Douki T, Martin P. Indirect genotoxicity of diesel engine emission: An in vivo study under controlled conditions. Toxicol Lett 2015. [DOI: 10.1016/j.toxlet.2015.08.226] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
44
|
Kalach N, Gosset P, Dehecq E, Decoster A, Spyckerelle C, Papadopolos S, Dupont C, Raymond J. Usefulness of Gastric Biopsy-Based Real-Time Polymerase Chain Reaction for the Diagnosis of Helicobacter pylori Infection in Children. J Pediatr Gastroenterol Nutr 2015; 61:307-12. [PMID: 25793904 DOI: 10.1097/mpg.0000000000000787] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 12/27/2022]
Abstract
OBJECTIVES The aim of the study was to assess the usefulness of gastric biopsy-based quantitative real-time polymerase chain reaction (qPCR) for the detection of Helicobacter pylori infection and the identification of clarithromycin-resistant strains in children. METHODS A gastric biopsy-based qPCR for the detection of H pylori infection and the identification of clarithromycin-resistant strains in children was evaluated in 62 children with infection and 341 children without infection. H pylori infection was considered by the "reference method" when culture was positive for both histology and rapid urease test (RUT). Results were compared with those obtained using the qPCR. RESULTS The reference method versus H pylori qPCR positivity showed 95% confidence interval sensitivity 100% versus 100%, specificity 93.2% (86.9-99.4) versus 100%, positive predictive value 59.7% (47.4-71.9) versus 100%, negative predictive value 100% versus 100%, and, finally, test accuracy of 59.6% (47.3-71.8) versus 100%. Sixty-two children were found to be H pylori positive, based on the qPCR results. Among those, 31 children had both positive qPCR and culture with concordant antimicrobial susceptibility testing results, whereas 31 children had negative culture and positive qPCR. The qPCR showed a bacterial load ≥10 copies per milliliter when culture, histology, and RUT were all positive (29/31 children) versus <10 copies per milliliter when culture, histology, and RUT were all negative (25/31 children). Grades 2 and 3 histological gastritis were associated with a bacterial load ≥10 copies per milliliter for 28/35 of children versus 27/27 of grade 0 to 1 <10 copies per milliliter. CONCLUSIONS H pylori qPCR positivity is a more precise test than the routine culture, histology, RUT alone and allows detecting low bacterial loads.
Collapse
Affiliation(s)
- Nicolas Kalach
- *Clinique Pédiatrique St Antoine †Département d'Anatomopathologie, Hôpital St Vincent de Paul ‡Département de Microbiologie, Hôpital St Philibert, Groupement des Hôpitaux de l'Institut Catholique de Lille, Lille §Service de Gastroentérologie Pédiatrique, Hôpital Necker-Enfants-malades, AP-HP
- Service de Microbiologie, Hôpital Cochin, Université Paris V-René Descartes, Paris, France
| | | | | | | | | | | | | | | |
Collapse
|
45
|
Chaouche-Mazouni S, Scherpereel A, Zaamoum R, Mihalache A, Amir ZC, Lebaïli N, Delaire B, Gosset P. Claudin 3, 4, and 15 expression in solid tumors of lung adenocarcinoma versus malignant pleural mesothelioma. Ann Diagn Pathol 2015; 19:193-7. [PMID: 25935651 DOI: 10.1016/j.anndiagpath.2015.03.007] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2014] [Revised: 03/09/2015] [Accepted: 03/28/2015] [Indexed: 12/17/2022]
Abstract
Epithelioid malignant pleural mesothelioma (MPM) can easily be confused with lung adenocarcinomas (ACAs). In serous effusion, claudin (cldn) 3 is shown to be useful in the diagnosis of mesothelioma vs ACAs. Cldn15 is reported to be overexpressed in epithelioid mesothelioma and absent in human airway epithelium. The aim was to assess the value of cldn3 and cldn4 compared to that of BerEp4 and thyroid transcription factor-1 (TTF1) in differentiating lung ACA from epithelioid MPM and to examine the expression of cldn15 in these tumors. The expression of cldn3, cldn4, cldn15, BerEp4, and TTF1 was examined by immunohistochemistry in a total of 62 human specimen including 28 epithelioid MPMs and 34 ACAs of the lung. In lung ACA, cldn4 was strongly expressed in all 34 (100%) specimens followed by cldn3 in 33 (97%) of 34. BerEp4 was expressed in 32 (94.1%) of 34. TTF1 reacted for only 20 (58.82%) of 34 cases of lung ACA. In MPM specimens, the expression of cldn3 and4 as well as that of TTF1 was completely absent. In contrast, BerEp4 was focally expressed in 5 (17.85%) of 28 cases of epithelioid MPM. Cldn15 was strongly expressed in 53% pf epithelioid MPMs but also in 50% of lung ACAs. Its expression was moderate in normal pleura and limited in normal lung. Cldn3 and cldn4 appear to be the best performing carcinoma markers in discriminating lung ACA from mesothelioma compared with BerEp4 and TTF1. There is no differential expression of cldn15 between the 2 pathologies. However, the limited cldn15 expression in normal tissues and high expression in tumors make it an attractive candidate for cancer therapy.
Collapse
Affiliation(s)
| | - Arnaud Scherpereel
- Department of Pulmonary and Thoracic Oncology, Lille University Hospital, Lille, France
| | - Rima Zaamoum
- Department of Pneumophtysiology, Public Hospital of Rouiba, Algeria
| | - Adriana Mihalache
- Department of Pathology, Hospital of St Vincent, GHICL, Lille, France
| | - Zine-Charaf Amir
- Department of Pathology, Hospital of Mustapha Pacha, Algiers, Algeria
| | - Nemcha Lebaïli
- Department of Biology, Kouba High School, Algiers, Algeria
| | - Baptiste Delaire
- Department of Pathology, Hospital of St Vincent, GHICL, Lille, France
| | - Pierre Gosset
- Department of Pathology, Hospital of St Vincent, GHICL, Lille, France
| |
Collapse
|
46
|
Desurmont T, Skrypek N, Duhamel A, Jonckheere N, Millet G, Leteurtre E, Gosset P, Duchene B, Ramdane N, Hebbar M, Van Seuningen I, Pruvot FR, Huet G, Truant S. Overexpression of chemokine receptor CXCR2 and ligand CXCL7 in liver metastases from colon cancer is correlated to shorter disease-free and overall survival. Cancer Sci 2015; 106:262-9. [PMID: 25580640 PMCID: PMC4376434 DOI: 10.1111/cas.12603] [Citation(s) in RCA: 59] [Impact Index Per Article: 6.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/05/2014] [Revised: 12/18/2014] [Accepted: 12/24/2014] [Indexed: 12/21/2022] Open
Abstract
Our aim was to analyze the potential role of chemokine receptors CXCR2 and CXCR4 signalling pathways in liver metastatic colorectal cancer (CRC) relapse. CXCR2, CXCR4, and their chemokine ligands were evaluated in liver metastases of colorectal cancer in order to study their correlation with overall and disease-free survival of patients having received, or not received, a neoadjuvant chemotherapy regimen. Quantitative RT-PCR and CXCR2 immunohistochemical staining were carried out using CRC liver metastasis samples. Expression levels of CXCR2, CXCR4, and their ligands were statistically analyzed according to treatment with neoadjuvant chemotherapy and patients’ outcome. CXCR2 and CXCL7 overexpression are correlated to shorter overall and disease-free survival. By multivariate analysis, CXCR2 and CXCL7 expressions are independent factors of overall and disease-free survival. Neoadjuvant chemotherapy increases significantly the expression of CXCR2: treated group 1.89 (0.02–50.92) vs 0.55 (0.07–3.22), P = 0.016. CXCL7 was overexpressed close to significance, 0.40 (0.00–7.85) vs 0.15 (0.01–7.88), P = 0.12. We show the involvement of CXCL7/CXCR2 signalling pathways as a predictive factor of poor outcome in metastatic CRC. 5-Fluorouracil-based chemotherapy regimens increase the expression of these genes in liver metastasis, providing one explanation for aggressiveness of relapsed drug-resistant tumors. Selective blockage of CXCR2/CXCL7 signalling pathways could provide new potential therapeutic opportunities.
Collapse
Affiliation(s)
- Thibault Desurmont
- Inserm, U837, Team-5 (Mucins, Epithelial Differentiation, and Carcinogenesis), Jean-Pierre Aubert Research Centre, Université Lille, France; Department of Digestive and Visceral Surgery, GHICL, Saint-Vincent de Paul Hospital, Lille, France
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
47
|
Moldovan SC, Dumitraşcu T, Mensier A, Desurmont T, Dominguez S, Cambier N, Moldovan AM, Gosset P, Popescu I. A posterior approach pancreaticoduodenectomy with portal vein resection in a large adenocarcinoma of the uncinate process of the pancreas - case report. Chirurgia (Bucur) 2015; 110:161-164. [PMID: 26011839] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 04/01/2015] [Indexed: 06/04/2023]
Abstract
A portal vein invasion is no longer a contraindication for resection in pancreatic cancer, but increased morbidity and mortality rates can be encountered. Hereby it is presented the case of a patient diagnosed with a large adenocarcinoma of the uncinate process of the pancreas, who underwent aposterior approach pancreaticoduodenectomy, with en bloctang ential resection of the portal vein, and total mesopan creasexcision. A posterior approach allows a negative resection margins pancreaticoduodenectomy, with a good local control of the disease, despite the in creas.
Collapse
|
48
|
Hennegrave F, Just N, Le Rouzic O, Sirard J, Pichavant M, Gosset P. Capacité des immunostimulants à restaurer une réponse IL-17, IL-22, IFN-γ dans le cadre de la BPCO. Rev Mal Respir 2015. [DOI: 10.1016/j.rmr.2015.02.037] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
49
|
Joncquel Chevalier Curt M, Lecointe K, Mihalache A, Rossez Y, Gosset P, Léonard R, Robbe-Masselot C. Alteration or adaptation, the two roads for human gastric mucin glycosylation infected by Helicobacter pylori. Glycobiology 2015; 25:617-31. [DOI: 10.1093/glycob/cwv004] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2014] [Accepted: 01/06/2015] [Indexed: 12/24/2022] Open
|
50
|
Olivier C, Le Rouzic O, Just N, Kervoaze G, Trottein F, Pichavant M, Gosset P. Altération de la production d’IFN-γ, IL-17 et IL-22 par les lymphocytes innés en réponse à l’infection au cours de la BPCO. Rev Mal Respir 2014. [DOI: 10.1016/j.rmr.2014.04.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|